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ABSTRACT 
 
Layered double hydroxides (LDHs) or hydrotalcite-like compounds (HTLcs) are 
classified as anionic clays in which their structure is based upon brucite and are 
represented by the following general chemical formula: 
    [MII1-xMIII x(OH)2]x+(An-)x/y.yH2O 
where MII and MIII represent various possible divalent cations, e.g., Mg2+, Zn2+, Ni2+, Co2+ 
and Fe2+ and trivalent cations, e.g., Al3+, Fe3+ and Cr3+ respectively. The value x is equal 
to the stoichiometric ratio of MIII/(MII+MIII) and An- represents exchangeable anions such 
as CO32-, Cl- and SO42-. It is these exchangeable interlayer anions, which make layered 
double hydroxide compounds excellent carriers of negatively charged or anionic 
containing biomolecules, such as DNA and hence can be exploited in their use in gene 
therapy. 
In this study, a variety of Mg-Al hydrotalcites (HTs), Zn-Al, Zn-Fe and Mg-Fe LDHs 
were synthesized using co-precipitation. The synthesized compounds were characterized 
by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman 
spectroscopy, Inductively coupled plasma-optical emission spectroscopy (ICP-OES), 
Transmission electron microscopy (TEM), Scanning electron microscopy (SEM) and 
Scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDX). XRD 
patterns for the synthesized HTs and LDHs exhibited characteristic features indicative of 
an ordered layered material. Elemental analysis of the compounds revealed a measured 
value of x in the range of 0.25-0.33 for Mg-Al HTs and Zn-Fe LDHs, 0.11-0.16 for Zn-Al 
LDHs and 0.55-0.58 for Mg-Fe LDHs. FTIR and Raman spectroscopy confirmed the 
presence of characteristic functional groups and interlayer anions. From electron 
microscopy, the compounds exhibited classical morphologies typical of HT and LDH 
compounds and had a lateral size range of 200-300 nm.  
These compounds were studied in their ability to bind DNA with the use of a gel 
retardation or band shift assay. This assay confirmed that these compounds are indeed 
able to bind DNA. The binding mechanism of DNA to the HT and LDH compounds was 
evaluated and plausible mechanisms were proposed. Furthermore, nuclease digestion 
assays were carried out in order to evaluate the potential protecting ability that these 
compounds afford towards the bound DNA in the presence of serum. It was observed that 
all compounds protected most of the bound DNA. The cytotoxicity of the compounds 
was evaluated in the HEK293, HepG2 and HeLa mammalian cell lines using the MTS (3-
(4,5-dimethylthiazol-2yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salts) assay with a concentration range of 20-100 μg of respective HT/LDH 
compound. For most of the compounds, cell viability was observed in excess of 80 %. 
Finally, transfection studies were carried out utilizing green fluorescent protein (GFP) 
analysis and luciferase gene expression using the same mammalian cells in culture. It was 
noted that all HTs and LDHs were able to release DNA in a controlled prolonged manner 
over a period of three days. Green fluorescent protein gene expression commenced after 
27 hours and reached a maximum at 72 hours. Efficient luciferase gene expression was 
observed with luciferase activities for DNA: HTs ranging from 0.05 x 106 - 2.0 x 106 
RLU / mg protein and DNA: LDHs ranging from 0.05 x 106 - 16.7 x 106 RLU / mg 
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DEFINITIONS AND CALCULATIONS 
 
1. Scherrer’s Equation: To calculate crystallite size 
Crystallite Size =    (K)(λ) 
    (B)(cosθB) 
where  K = XRD instrument standard constant 
  λ  = X-ray wavelength 
  B = Full width at half maximum (FWHM) of peak corresponding  
       to 100 % intensity 
   θB=Bragg angle or 2-theta angle of peak corresponding to 100%  
       intensity 
 
2. Value of x: 
x =                 MIII 
  (MII + MIII) 
 where         MII  = Divalent cation 



















DNA  : Deoxyribonucleic acid 
EDX  : Energy dispersive X-ray spectrometry 
FCS  : Fetal calf serum 
FITC  : Flourescein-5-isothiocyanate 
FTIR  : Fourier transform infrared spectroscopy 
GFP  : Green fluorescent protein 
HEK293 : Human embryonic kidney cell line 293 
HT  : Hydrotalcite 
HTLc  : Hydrotalcite-like compounds 
ICP-OES : Inductively coupled plasma-optical emission spectroscopy 
IR  : Infrared spectroscopy 
LDH  : Layered double hydroxide 
pCMV : Plasmid containing cytomegalovirus promotor 
RLU  : Relative light units 
SEM  : Scanning electron microscopy 
SEM-EDX : Scanning electron microscopy-energy dispersive X-ray  
spectrometry 
TEM  : Transmission electron microscopy 
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1.1 Historical background 
 
Since the discovery of naturally forming hydrotalcite (HT) in Sweden in the early 1940s, 
hydrotalcite-like (HTLc) or layered double hydroxides (LDHs) have been studied in their 
use as catalysts and precursors to various other catalysts as early as 1970 [1, 2]. The 
application of HTs (Mg-Al) in gene delivery studies was first published in 2000 by Choy 
et al. [3]. Since then, researchers have continued to use Mg-Al HTs in gene delivery 
studies specifically focusing on the optimization of synthesis conditions, particle size and 
the elucidation of mechanisms of deoxyribonucleic acid (DNA) binding and cellular 
uptake.  
Shortly after the discovery of naturally forming HT, a German scientist, W. Feitknecht, 
synthesized a variety of HTLc compounds which he named “doppelschichtstrukturen” or 
double sheet structure [1]. Feitknecht described these structures as having a layer of 
hydroxide of one cation followed by a hydroxide layer of the second cation.  
 
 
   




Figure 1.1 Figure depicting “doppelschichtstrukturen”, coloured lines indicate layered 
structure (Adapted from [1]). 
 
Feitknecht‟s theory was later disproved and corrected by the pioneering work of Allman 
and Taylor in which their single crystal X-ray diffraction studies carried out on mineral 
samples revealed the main structural entities of LDHs [4]. These studies showed that the 
two cations were in fact located in a single layer and the interlayers were composed of 
 2 
water and carbonate ions. Although the main entities of LDHs have been elucidated, 
Evans and Slade [4] have suggested that several intrinsic details still remain to be fully 
understood. These include the possible stoichiometric range and composition, the 
position and arrangement of metals within each cationic layer. In addition, the extent at 
which these layers associate with the interlayer and its various range of possible anions. 
Previous to the study by Evans and Slade, Miyata [5, 6] and Miyata and Okada [7] 
described many structural features of HTs and LDHs containing different guest anions. 
From their findings, these authors were able to describe the relation of synthetic HTs and 
LDHs to that of brucite and Cd(OH)2-like structures. Layered double hydroxides are 
classified as clays. According to Annabi-Bergaya [8], although clay science has been 
investigated for a long time, breakthroughs in this area have only occured in the last 
decade. Annabi-Bergaya has forecasted that clays will be important materials of the 
future and their understanding will constantly evolve as more data becomes available.  
 
1.2 Clay minerals 
 
Clays are found in abundance in nature and are usually formed from the weathering and 
decomposition of silicate and igneous materials at the surface of the earth [9, 10]. Clays 
are layered materials and are classified within the phyllosilicates. The layers are based on 
a two-dimensional stack of inorganic layers. Each layer is composed of either tetrahedral 
sheets of SiO2, octahedral sheets of metal oxide and hydroxide (LDHs) or both [10]. 
Hydrogen bonding and van der waals interactions between cations, interlayer anions and 
water molecules ensure that the layered organization is maintained between subsequent 
sheets. Clays are classified into two broad groups, viz., cationic clays, widespread in 
nature and the less common, anionic clays. The application of clays include the 
preparation of ceramics and building materials, paper coatings and fillings, drilling muds, 
foundry moulds, cat litters, pharmaceuticals, adsorbents, catalysts or catalyst supports, 
ion exchangers, decolorizing agents, environmental remediation, polymers, electronics 





Clay minerals are based upon hydrous layer silicates of the phyllosilicate family, which 
are built upon tetrahedral Si(-O,-OH) and octahedral M(-O,-OH)6 sheets. Different 
combinations of these sheets give rise to different forms of cationic clays. When one 
tetrahedral sheet joins an octahedral sheet, a 1:1 clay mineral is formed, e.g., kaolinite. 
Furthermore, when an octahedral sheet is wedged between two tetrahedral sheets, a 2:1 
clay mineral is formed, e.g., pyrophyllite and montmorillonite. It is possible for Si 
substitution or replacement by various other cations such as Al, Mg and Fe resulting in a 
negative charge balance within the sheets. This charge is balanced by various other 
inorganic cations provided by the soil and hence resulting in an overall positive charge, 
hence the term cationic clay minerals [10-12].  
 
Anionic clays 
Although anionic clays are classified as phyllosilicate clay materials, their structure is 
based on brucite (Mg(OH)2) instead of silicate. Each Mg cation is octahedrally 
surrounded by hydroxyl groups forming an infinite sheet or layer (Figure 1.2).  
 
Figure 1.2 Figure depicting the structure of hydrotalcite-like compounds (Redrawn and 



















Anionic clays are also termed hydrotalcite-like compounds (HTLcs) or layered double 
hydroxides (LDHs). As with cationic clays, cation substitution or replacement is also 
possible giving rise to a wide variety of isomorphous materials. When cations are 
replaced by cations with a higher valency than those within the brucite-like sheet, the 
brucite-like sheets bear an overall positive charge, in which counter balance is provided 
by extra-framework interlayer anions [10-15]. 
Currently, there is considerable interest in the ion exchange of various anionic 
pharmaceutically important molecules into the interlayer region of LDHs. In addition, 
they have higher anion exchange capacities than other anionic exchange resins and have 
the added advantage of being readily synthesized in the laboratory from a variety of 
desired precursors. The chemical composition and structure of LDHs plays an important 
role in the ion exchange capacity of these anionic clays [15-17].  
 
1.3 LDH structure and composition 
 
LDHs are chemically classified as anionic clays in which their structure (Figure 1.3) is 
based on brucite layers (Mg(OH)2) [18].  
 
 
Figure 1.3 Diagrammatic representation of LDH compound (Redrawn from [11] 
using Macromedia Freehand MX Software, 2004). (MII = Mg2+, Zn2+, Ni2+, Co2+ and 







Figure 1.4 Figure depicting, (A) a single layer of the structure of Cd atoms coordinated 
to halogen atoms, and (B) hexagonal unit cell found within layers of (A) (Redrawn and 
adapted from [19, 20]). 
 
Each Mg2+ ion is coordinated octahedrally towards OH- ions (Figure 1.2) and exhibits a 
close-packing structure based on the AX2 structure, similar to that observed in cadmium 
iodide (CdI2) (Figure 1.4). Furthermore, each octahedral unit shares edges between 
subsequent octahedral units and hence forms an infinite sheet. These sheets stack on top 
of one another and are held together by hydrogen bonds with the OH- ion positioned 
perpendicular to each sheet [4]. When Mg2+ is replaced by a trivalent cation similar in 
radius, an overall positive charge results in the hydroxyl sheets and counter balance is 
provided by carbonate ions which are positioned within the hydroxyl interlayer. In 
addition to carbonate ions, water molecules are found in the interlayer gallery. The nature 
of the interlayer anion and the extent of hydration often determine the layer spacing 
between each brucite-like sheet [21].Within the two-dimensional hydroxyl sheets it has 
been speculated that there is further ordering of the trivalent and divalent cations. 
Furthermore, it has been postulated that the trivalent cations are unlikely to position 
themselves, side on, neighboring each other in cation sites [22]. As a result of the 
trivalent cations occupying non-neighboring sites, the ratio of trivalent to divalent cation 
should result in an entirely ordered superlattice with unit-cell parameters in the brucite-
like sheets of √3a (where a represents the average cation-cation distance) and the 
hexagonal lattice rotated by 30o from that of brucite [22]. The brucite-like sheets may 
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occur in two different symmetries, namely rhombohedral and hexagonal. In nature, the 
rhombohedral symmetry is wide spread. However, in mineral samples, the hexagonal 
symmetry is seen to favour the interior of the crystallite samples, while the rhombohedral 
symmetry is found on the exterior. This is a result of cooling during crystallite 
transformation, in which the exterior surface of the crystallite cools much quicker than 
the interior and hence the interior hexagonal form cannot transform due to a higher 
energy transformation barrier at lower temperatures. From these observations, it has been 
deduced that the hexagonal symmetry is favored by high temperatures [1,5]. Naturally 
occurring minerals that exhibit a LDH structure include manasseite, pyroaurite, 
sjogrenite, barbetonite, takovite, reevesite, desautelsite and stichtite. They differ from one 
another in the stacking arrangement of the octahedral layers [1, 23].  
LDHs are represented by the following general chemical formula: 
    [MII1-xMIII x(OH)2]x+(An-)x/y.yH2O  
where MII and MIII represent various possible divalent cations, e.g., Mg2+, Zn2+, Ni2+, Co2+ 
and Fe2+ and trivalent cations, e.g., Al3+, Fe3+ and Cr3+ respectively and An- represents 
exchangeable anions, e.g., CO32-, Cl- and SO42-. Stoichiometric ratios, x and y may be 
altered to give varying types of LDH iso-structural materials [13, 18, 24-28]. The value x 
is equal to the stoichiometric ratio of MIII/(MII+MIII). Thus, the typical LDH structure can 
be simplistically viewed as alternating layers of cations upon counter anions within 
hydroxyl sheets. 
 
1.4 Possible range of MII  and MIII ions 
 
Any divalent or trivalent ion that is capable of being positioned in the close packed 
configuration of the hydroxyl groups of the brucite-like layers can form a hydrotalcite-
like structure. Most of the divalent metal ions (Be2+, Mg2+, Cu2+, Ni2+, Co2+, Zn2+, Fe2+, 
Mn2+, Cd2+ and Ca2+) form LDHs, with the exception of Cu2+ which forms a LDH 
structure only when another divalent cation is present. However, with this additional 
divalent cation present, the ratio between the Cu2+ ion and the additional ion should be 
equal to or lower than one. A ratio above one, results in the Jahn-Teller effect which is 
due to the gain in energy derived from a distorted octahedral coordination structure. The 
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Cu2+ ions are positioned in close proximity of one another in near-lying octahedra and 
hence the formation of a distorted octahedral structure is energetically favourable than 
that of a LDH [1]. LDH compounds containing Cu2+ ions have been prepared and 
characterized although copper containing materials show a corrugation of the sheets 
associated with the Jahn-Teller distortion [4, 29]. Trivalent ions, with the exception of 
Ti3+ and V3+, with atomic radii ranging from 0.50-0.8 Å form LDH structures. More 
recently, Islam and Patel [17] have synthesized LDHs containing thorium (IV), while 
others have synthesized LDHs containing Zr4+, Sn4+, Ti4+ and Si4+ [30, 31]. However, 
much doubt has been cast on these tetravalent containing LDHs [32]. According to Evans 
and Slade [4], it has been clearly shown by X-ray absorption spectroscopy and 
Mössbauer spectroscopy, that tetravalent cations separate from the LDH structure and 
form tetravalent oxide-like compounds. Layered double hydroxides containing 
monovalent lithium have been successfully prepared and characterized [33]. 
 
1.5 Possible values of x 
 
Pure phases of LDH compounds are produced when x falls in the range of 0.2 ≤ x ≤ 0.33. 
However, HT and LDH compounds with x ranging from 0.1-0.5 have been synthesized. 
There is doubt as to whether these compounds are indeed pure phases since Mg(OH)2 and 
Al(OH)3, in most cases are not detectable by X-ray measurements [1, 4, 5, 11, 33-36]. 
López-Salinas et al. [37] reported the synthesis of Mg-Ga-CO3 LDHs for a value of x as 
low as 0.07. Also, values of x in the range of 0.17-0.18 have been reported for Mg-Al-
CO3 and Mg-Ga-CO3 LDHs [38]. In addition, LDHs with values of x as high as 0.4 - 1.0 
have been synthesized [6, 39-41] including FeII-FeIII with a value of 0.5 [42]. According 
to Brindley and Kikkawa [34], in compounds where the value of x is lower than 0.33, the 
Al octahedra are non-neighbouring. However, when the value of x is greater than 0.33, 






1.6 LDH interlayer 
 
The interlayers of LDHs contain both anions and water molecules [1, 4, 5, 11, 21, 43-45]. 
Within these interlayers there exists a network of electrostatic and hydrogen bonding 
between the hydroxyl groups, anions and water molecules. It is the number, size, 
orientation, and strength of the bonds between the anions and the hydroxyl groups that 
determine the thickness of the interlayer. The oxygen atoms of both carbonate and water 
anions are positioned in sites very close to the symmetry axes of hydroxyl groups located 
perpendicularly to adjacent brucite-like layers. This is due to the close proximity of the 
oxygen atoms in each group, only one site is occupied, therefore, three adjacent sets of 
sites are filled by the oxygen atoms for each carbonate group. According to Cavani et al. 
[1], water molecules form a tetrahedral configuration through hydrogen bonding between 
nearby oxygen atoms or hydroxyl groups, whereas Evans and Slade [4] state that the 
hydroxyl groups bonded to trivalent cations are strongly polarized and interact with the 
interlayer anions. Thus, every anion is required to satisfy the excess positive charge of 
both adjacent octahedral layers which are electrically balanced by two neighbouring 
interlayers. It has been suggested that charge compensation in LDHs has features 
characteristic of resonance effects. The interlayer arrangement described, is found in the 
hydroxide, carbonate, nitrate and chloride LDHs. Cavani and co-workers [1] also 
observed that sulphate (SO4)2- and chlorate (ClO4)- containing LDHs exhibit a different 
interlayer arrangement to those containing nitrate or carbonate. This observation is 
attributed to the difference in geometries that sulphate and chlorate anions exhibit. The 
amount of water (y) in the interlayer of LDHs may be calculated from thermogravimetric 
measurements of weight loss. Alternatively, the amount of water may be calculated from 
the total number of sites occupied by oxygen subtracting the sites occupied by the anions 
[11]. According to Miyata [6], the amount of water may be calculated by assuming a 
close packed configuration using the equation, y = 1-Nx/n, where N = the number of sites 
occupied by the anion, x = MIII/(MII+MIII), and n = charge of the anion. For (CO3)2- , y = 
1-3x/ 2. However, it has been argued by Evans and Slade [4] that when calculating the 
amount of water in the interlayers, the extrinsic water that can be adsorbed onto the 
external surface of the LDH should be taken into consideration. A wide variety of anions 
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have been incorporated into the interlayer region of LDHs that have resulted in their 
application in catalysis [1, 46-56], industry and agriculture [1, 18, 57-59], ion exchangers 
[1, 58, 60], conductors [61], insulators [1], pharmaceutics [1, 13, 16, 26, 27, 62-74], 
corrosion inhibitors [1] and magnetic materials [18] (Table 1.1). The incorporation of 
these anions into the interlayer region is due to the ion exchange nature that HTs and 
LDHs exibit [11, 12]. It is these exchangeable interlayer anions in the LDH structure, 
which make these compounds excellent carriers of negatively charged or anionic 
containing biomolecules, such as DNA and hence can be exploited in their use in gene 
therapy.  
 
Table 1.1 Interlayer anions of various synthesized HTs and LDHs 
Interlayer anion Reference 
Inorganic anions: Cl-, (CrO4) 2- , (NO3) -, (SO4) 2- , (CO3)2-  [44] 
 Br-, F-, I-, Cl-,(NO3) -,(CO3)2-  [7] 
 [Co(CN)6] 3-  [44] 
 OH-  [75] 
 (ClO4) - [34] 
 (HPO4) 2-  [76] 
 (ClO4) -  [6] 
 (V10O28) 6-  [77] 
 [Fe(CN)6] 3-, [Fe(CN)6] 4-  [40] 
 [SiO3] 2-, (Mo7O24)6- , (Cr2O7) 2-  [43] 
 [Rh0]  [46] 
 
HRh(CO)(TPPTS)3 (TPPTS = tris(3-sodium 
sulfonatophenyl) phosphine)  [78] 
Organic 
molecules: 
Acetate, terephthalate and benzoate  [79] 
 Benzenedicarboxylates and napthalenesulfonates  [80] 
 2,4-dichlorophenoxyacetate  [81] 
 Oxalic acid, adipic acid, succinic acid, tartric acid  [82] 
 Phosphonic Acid  [83] 
 Acetate  [62] 
 Terephthalate, biphenyl-4,4'-dicarboxylate  [84] 
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Table 1.1 Continued 
Layered 
compounds:  
Mineral chlorite,  (Mg2Al(OH)6)+.[Mg3(OH)2/Si3AlO10]-  [1] 
Surfactants: Alkyl-sulphates, alkanesulphonates  [85] 
 
Octylsulphonate, octanebenzenesulphonate, 
dodecylbenzenesulphonate, octadecanesulphonate  [86] 
Pharmaceuticals: Gramicidin, amphotericin B, ampicillin, nalidixic acid  [16] 
 Phenylphosphonic acid  [87] 
 Gliclazide  [63] 
 Fenbufen [13] 
 Heparin  [64] 
 L-ascorbic acid  [65] 
 Mefenamic and meclofenamic acid  [66] 
 Podophyllotoxin [67] 
Biomolecules: 
 
Amino acids, oligopeptides  [68, 69] 
 
Monotriphosphates, Flourescein-5-isothiocyanate (FITC), c-
myc antisense oligonucleotide  [71] 
 Small interfering ribonucleic acid (siRNA) [88, 89] 
 Deoxyribonucleic Acid (DNA)  [26, 27, 73] 
 
 
1.7 Gene therapy 
 
The idea of correcting an inherited or acquired genetic error has been in existence since 
the early 1930s when the term „genetic engineering‟ was first described [90]. However, it 
was only until a decade later that Avery et al. [91] described the notion of the inducible 
delivery of deoxyribonucleic acid (DNA) into bacterial cells and hence illustrating DNA 
transfection in pneumococcal strains. Avery‟s findings, coupled with the discovery of the 
structure of DNA and its genetic implications sparked the beginning of the gene therapy 
era. The idea of the delivery of exogenous or foreign DNA into cells encouraged 
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researchers to investigate whether this strategy could be exploited in the delivery of a 
therapeutic gene into diseased human cells. From the early 1950s till the late 1980s the 
field of gene therapy was largely dominated by the use of modified viruses in the delivery 
of a therapeutic gene to diseased mammalian cells due to the high efficiency that these 
modified viruses afforded. Among the first non-viral gene therapy methods used during 
this time included the use of DEAE dextran [92] and calcium phosphate co-precipitation 
[93]. A major development in gene therapy was the first human gene therapy ex vivo 
experiment carried out on patients in the 1990‟s by the National Institute of Health (NIH) 
USA, in which a four-year old patient whom suffered from severe combined 
immunodeficiency (SCID) underwent gene therapy. The goal was to insert a therapeutic 
gene (ADA gene, coding for adenosine deaminase) into healthy lymphocytes and 
reintroduce these modified lymphocytes into the patient. A new drug therapy that had 
been developed in treating SCID was simultaneously administered to the patient. To date, 
this patient is still receiving the drug treatment, however, the NIH remains unsure as to 
whether the gene therapy initially administered, was a dominant factor in this patient‟s 
healthy recovery [94]. During this time Rosenberg et al. [95] reported an ex vivo gene 
transfer trial in patients suffering from melanoma using modified lymphocytes containing 
an inserted therapeutic gene by retroviral gene transduction. A number of other such 
experiments done in the late 1990s, including in vivo studies, resulted in the deaths of 
many patients due to the body‟s response towards the vector used in the gene therapy 
strategy, most of which have been viral vectors. Although gene therapy using modified 
viruses appears very efficient, the adverse activation of the immune response towards 
these introduced modified viruses greatly impaired the development of viral gene therapy 
research. Thus, for many years, gene therapy researchers have been striving to develop an 
ideal non-viral or improved viral vector for the delivery of a therapeutic gene into 
diseased mammalian cells. According to research, an „ideal‟ gene therapy vector should 
have the following properties:  ability to deliver a therapeutic gene safely into a cell, have 
a high loading capacity, exhibit little or no toxicity, non-immunogenic, biodegradable, 
include a wide availability, stable during storage and after administration, have the ability 
to target specific cells and afford relatively efficient gene expression [27, 96]. Of the 
many vectors that have been developed, a select few can satisfy all of the above 
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requirements. The wide variety of viral vectors that have been utilized in gene delivery 
include the Retrovirus, Adenovirus, Adeno-Associated virus and Herpes simplex virus. 
Although viral vectors are amongst the most efficient in gene delivery vectors, a majority 
of the viral vectors have numerous disadvantages such as the inability to produce high 
titers of the modified virus, elevated cytotoxicity and activation of the immune response 
resulting from replication competent viral particles.  
Non-viral vectors on the other hand, such as the direct gene gun method, liposomes, lipid 
based molecules, polymers, organic and inorganic nanoparticles, as well as other 
biomaterials exhibit properties such as lower immunogenic effects, simplicity and 
feasibility to large scale production. Although many of these non-viral vectors exhibit 
properties rendering them as attractive alternatives to the use of viral vectors, the 
drawbacks of many non-viral vectors include adverse cytotoxic and biological effects, 
low gene delivery efficiency and transient gene expression. Despite these drawbacks, 
researchers have pressed on in the search, design and synthesis of more favorable non-
viral vectors. A fairly recent non-viral vector that is receiving much attention due its 
favorable „ideal‟ properties is that of LDHs [71]. A LDH compound posseses versatile 
properties that make them appropriate for gene therapy such as good biocompatibility, 
low cytotoxicity, diverse functionality, controllable particle sizes, wide availability, high 
loading capacities, protection of biomolecules in the interlayers and the potential 
capability of targeted delivery and controlled release of carried genes [25-28, 71]. Of the 
various studies utilizing these compounds in gene therapy, many have been conducted on 
Mg-Al HTs since their structural and chemical nature have been extensively studied. 
Cytotoxicity studies on Mg-Al HT compounds have been carried out and have been 
found to cause minimal cell death [25-28, 71]. To date, HT compounds have been 
utilized as carriers of DNA, monotriphosphates, flourescien-5-isothiocyanate (FITC), c-
myc antisense oligonucleotide (As-myc), small interfering ribonucleic acid (siRNA) and 






1.8 Motivation and objectives of study 
 
Mg-Al HTs have shown immense potential as an alternative non-viral vector in gene 
therapy as they exhibit properties rendering them as an „ideal‟ vector [25-28, 71]. 
Although the use of Mg-Al HTs in gene therapy has attracted much attention, no work 
has been published on the application of LDHs of varying cationic compositions in gene 
therapy strategies. Thus considering the properties exhibited by HTs, the need to further 
investigate LDHs of varying compositions in gene delivery strategies would provide 
insight into the effects of varying cationic compositions and their effectiveness in relation 
to Mg-Al HTs. These findings would thus have a direct impact in developing HTs and 
LDHs into in vivo models and eventually the use in treating a patient suffering from 
perhaps a debilitating genetic disease. Literature has suggested that the mechanism of 
HT-DNA complex formation occurs via ion-exchange, whether this mechanism indeed 
occurs in LDH-DNA complexes will be explored [25-28]. Furthermore, the potential 
application of these compounds in gene delivery to mammalian cells in culture will be 
investigated.  These insights will provide a greater understanding of the use of LDHs in 
gene therapy and will pave a way forward in order to improve current non-viral gene 
therapy strategies using these compounds as well as to ascertain their future in gene 
delivery strategies. 
 
The objective of this study was to synthesize different combination of compounds with 
the formula: 
[MII1-xMIII x(OH)2]x+(An-)x/y.yH2O 
where MII=Mg2+, Zn2+ and MIII=Al3+, Fe3+  and to investigate their potential application in 
gene delivery to mammalian cells in culture. These compounds were characterized using 
X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman 
spectroscopy, Inductively coupled plasma-optical emission spectroscopy (ICP-OES), 
Transmission electron microscopy (TEM),  Scanning electron microscopy (SEM) and 
Scanning electron microscopy-energy dispersive x-ray spectroscopy (SEM-EDX). 
Thereafter their DNA binding abilities, cytotoxicities as well as transfection activities 
were examined in vitro using the HepG2, HEK293 and HeLa mammalian cell lines.  
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CHAPTER TWO 
SYNTHESIS AND CHARACTERIZATION OF HYDROTALCITES (HTs) 




Layered double hydroxides have been synthesized by various techniques. Some of the 
most popular and extensively used techniques include co-precipitation, hydrothermal 
methods and ion exchange [1, 4, 5, 7, 11].  
  




Co-precipitation remains the most commonly used technique for the synthesis of LDHs. 
This technique involves the addition of aqueous solutions of MII, MIII and the anion that 
is to be incorporated into the LDH structure. The direct addition of prepared precursors 
allow for a variety of cations and anions to be incorporated into the formulation of 
various LDHs. Co-precipitation is also the method commonly used in the formulation of 
organic anion LDHs which are difficult to obtain by other methods [4]. For the co-
precipitation of two or more cations, it is essential to maintain the reaction mixture in a 
state of supersaturation. Supersaturation is achieved physically by evaporation or 
chemically by controlling pH [1]. It has been observed that in order for co-precipitation 
to progress, the pH should be maintained at a value equal to or higher than the one at 









The optimum pH for precipitation of the hydroxides of some common metals used in 
LDH preparation is shown in Table 2.1. 
 
Table 2.1 Optimum pH of precipitation for some common divalent and trivalent ions [1] 
Cation pH ([0.01] M) pH ([0.0001] M) pH (hydroxide re-dissolves) 
Mn2+ 8.5 10.0  
Co2+ 7.5   9.5  
Fe2+ 7.5   6.5  
Ni2+ 7.0   8.0  
Zn2+ 6.5   8.5 14.0 
Cu2+ 5.0   9.0  
Cr3+ 5.0   9.0 12.5 
Al3+ 3.9 10.0 9.0-12.0 
 
Subsequent to the co-precipitation reaction, thermal treatment is typically employed in 
order to increase product yield and/or the crystallinity of the product [4]. There are three 
methods of co-preciptation that have been employed in the synthesis of LDHs, viz., 
titration, precipitation at low supersaturation and precipitation at high supersaturation [1]. 
 
Titration method 
The titration method involves the sequential addition of alkali to the reaction vessel 
containing the various precursors, yielding a gradual precipitation curve. From the 
precipitation curve, the optimum precipitation range is determined. However, due to a 
sequential precipitation of ions it is not possible to obtain pure LDHs. This method was 
first used by Feitknecht where LDHs were prepared by titration of dilute solutions of 
Mg2+ and Al3+ with a dilute sodium hydroxide solution up to a pH of 10. The resulting 
flocculated precipitate was placed in a dialysis bag and immersed in water at 333 K for 
one month. During this time, sodium and chlorine ions were removed and carbon dioxide 







Co-precipitation at low supersaturation 
Precipitation at low supersaturation is achieved by the slow addition of a mixed solution 
of divalent (MII) and trivalent (MIII) metal salts into a reaction vessel containing an 
aqueous solution of the desired interlayer anion. During the addition of the mixed metal 
salt solution, an alkali solution is added simultaneously to maintain a constant pH within 
the reaction solution. According to Evans and Slade [4], the anion that is to be 
incorporated into the LDH should have a high affinity for the LDH interlayer and should 
be in excess, otherwise counter-anions of the metal salts may be incorporated by 
competing for vacancies in the interlayers. Thus, metal chloride and metal nitrate salts are 
preferred due to the low selectivity that LDHs afford towards these anions. Low 
supersaturation gives rise to precipitates which are highly crystalline. In addition to a 
high degree of crystallininty, a large number of particles are obtained and are usually 
small in size [1]. 
 
Co-precipitation at high supersaturation 
Precipitation at high supersaturation is achieved by the addition of a mixed metal salt 
solution containing divalent and trivalent metal ions to an alkali solution of the desired 
interlayer anion [4]. This method usually gives rise to particles with a lower degree of 
crystallinity due to the high number of crystallization nuclei. Also, when using this 
method, it has been observed that high levels of impurites such as M(OH)2 or M(OH)3 
phases and LDHs with undesired MII/MIII ratios are obtained [4].  
 
2.1.1.2 Hydrothermal techniques 
 
Hydrothermal preparation methods have been employed in order to control the particle 
size and distribution when soluble magnesium and aluminium salts were used together 
with alkali solutions to prepare Mg-Al-carbonate LDHs and to transform amorphous 
precipitates into crystalline LDHs [1, 4]. There are two routes to hydrothermal treatment. 
In the first case, materials are treated at temperatures more than 373 K in a pressured 
autoclave. Here, the LDHs may be synthesized from precursors such as MgO and Al2O3 
or from mixtures obtained from the decomposition of the nitrate forms of these 
precursors [1, 78, 97]. More specifically, the precursors are placed in an autoclave set at 
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temperatures above 596 K and pressures between 10-130 MPa for a fixed time period. In 
the other case, LDHs are synthesized at low temperatures and undergo a process of aging. 
Aging involves refluxing the precipitate at a set temperature for 18 hours. 
 
2.1.1.3 Ion exchange 
 
This technique involves the exchange of the interlayer anions with anionic guest 
molecules, i.e., molecules one wishes to introduce into the LDH structure in order to 




Figure 2.1 Figure depicting ion exchange (Adapted from [15]). 
 
Ion exchange may occur in one of two ways, the first involves an anionic precursor 
containing weak anions such as NO3-, Cl- and ClO4-, which exhibit weak electrostatic 
interactions with the brucite-like sheets. The introduction of a guest molecule into the 
reaction vessel would favour the release of the weak interacting anions and allow the 
incorporation of guest anions within the LDH interlayer regions. The second method 
involves anion precursors such as carboxylates, carbonates and terephthalate which are 
susceptible to acidic attack. Synthesis of LDHs using ion exchange methods have been 
carried out by a number of researchers [6, 21, 31, 44, 72, 77, 84]. Drezdzon [77] 
synthesized Mg-Al-OH-tetraphthalate dianion (TA) using traditional co-precipitation 
methods. This compound was added to a solution containing a desired anion, Mo7O246-, 
provided by Na2MoO4.2H2O followed by slow addition of 4 N HNO3 to the mixture in 
order to partially digest the HT-like-TA. The digestion together with vigorous stirring at 
room temperature allowed for exchange of TA for the molybdate ion Mo7O246-. Suzuki et 
al. [44] synthesized a variety of LDH minerals of the formula Mg-AI-X where X = NO3- , 
CI-, SO42-, or CrO42-. These materials were intercalated with Co(CN)63- by an anion 









exchange method to produce Mg-Al-CN HTs. According to He et al. [15], there are 
several factors which determine the extent of ion exchange. These include: 
 
The affinity for the incoming guest anion 
The exchange ability of incoming guest anions increases with increasing negative charge 
and decreasing ionic radii. For inorganic anions the following trend is observed: 
divalent anions, CO32-  > HPO42-  > SO42-   
monovalent anions,OH-  > F-  > Cl-  > Br -  > NO3-  > I-. 
Nitrate ions are considered to have one of the weakest affinities for the LDH layers, 
hence its frequent use in the preparation of HT and LDH compounds. 
 
The medium in which the exchange occurs 
The medium in which the ion exchange reaction occurs can expand the interlayer 
favouring ion exchange [15]. An aqueous medium favours the exchange by inorganic 
anions, whilst an organic medium favours the exchange by organic ions.  
 
The pH 
A low pH value favours the release of the original anion as the conjugate acid and the 
incorporation of a less basic anion from the solution. However, the pH should not be 
below 4, as the basic LDH layers will begin to dissociate [15].  
 
The chemical composition of the LDH brucite-like layers 
The interlayer spacing of the LDH may be contracted or expanded depending on the 
interlayer anion. A number of interlayer spacing values have been reported, in which 










Table 2.2 Interlayer spacing values of some common interlayer anions [1] 











According to Meyn et al. [100], the interlayer arrangement of organic anions depends 
strongly on the area available to them. Studies were carried out on the available area and 
the degree in which alkyl chain compounds positioned themselves within the LDH 
interlayers. It was found that a small available area resulted in the alkyl chain compounds 
positioning themselves by pointing away from the interlayer surface to form monolayer 
films of high regularity. In the case of secondary alkane-sulphonate compounds, a similar 
observation was made with the formation of bilayer films within the interlayers. Crepaldi 
et al. [101] utilized an unconventional ion exchange method in which they relied on the 
interaction of cationic and anionic surfactants. The LDHs were synthesized containing an 
intercalated anionic surfactant, e.g., dodecylsulphate or dodecylbenzenesulphonate. 
Thereafter, a cationic surfactant, e.g., N-cetyl-N,N,N-trimethylammonium bromide is 
added together with a solution containing the desired anion that is to be incorporated into 
the LDH interlayer. The strong interaction between cationic and anionic surfactant 
favours the release of the anionic surfactant into solution and binds to the cationic 
surfactant. The vacancies left in the LDH from the released anionic surfactant is filled by 







2.1.2 Preparation of HTs and LDHs 
 
The HTs and LDHs were prepared using the co-precipitation technique at low 
supersaturation. In a typical experimental preparation, calculated amounts of nitrate 
precursors of magnesium, Mg(NO3)2.6H2O (Saar Chem, Krugersdorp, R. S. A.) and  
aluminium, Al(NO3)2.9H2O (Reidel-De Haën AG Seelze-Hanover) were dissolved in 200 
ml of double distilled water. The metal salt solution was added dropwise to a solution of 
sodium carbonate (Merck Chemicals, Gauteng, R.S.A.) with vigorous stirring. Sodium 
hydroxide (1 M) was added intermittently to maintain a pH of 11. A white gelatinous 
precipitate was obtained after the complete addition of the metal solution. The suspension 
was placed in a round bottom flask and heated under reflux at 80 oC for 18 hours. The 
precipitate was then filtered and washed thoroughly with distilled water until the filtrate 
reached a neutral pH. The precipitate was dried in an oven for 12 hours at 110 oC. Other 
materials were prepared using a similar method. Relevant calculations and the calculated 
amounts of precursors can be found in the appendix (Table A1). The prepared HTs and 
LDHs samples were named according to Table 2.3. 
 
Table 2.3 Prepared HT and LDH samples with corresponding abbreviation  
Compound Stoichiometry (x) Abbreviation 
Mg-Al HT 0.25 MgAl.25 
 0.30 MgAl.30 
 0.33 MgAl.33 
Zn-Al LDH 0.11 ZnAl.11 
 0.14 ZnAl.14 
 0.16 ZnAl.16 
Zn-Fe LDH 0.25 ZnFe.25 
 0.30 ZnFe.30 
 0.33 ZnFe.33 
Mg-Fe LDH 0.55 MgFe.55 
 0.58 MgFe.58 




2.1.3 Characterization of HTs and LDHs 
In the present study, Inductively coupled plasma-optical emission spectroscopy (ICP-
OES), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman 
spectroscopy, Transmission electron microscopy (TEM), Scanning electron microscopy 
(SEM) and scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-
EDX) were utilized in the characterization of all HT and LDH samples. 
 
2.1.3.1 Inductively coupled plasma-optical emission spectroscopy (ICP-OES) 
 
Inductively coupled plasma-optical emission spectroscopy (ICP-OES) is classified as 
optical atomic emission spectroscopy. In atomic emission spectroscopy, atoms of a 
sample are excited by an external energy source, supplied by plasma, in the form of heat 
or electrical energy. Once subjected to a form of external energy, molecules are promoted 
to higher electronic states termed as an excited state. The excited atoms last for a few 
nanoseconds in this state and quickly return to the ground state, simultaneously releasing 
their gained energy in the form of photons of visible or ultraviolet radiation. A 
spectrometer is often incorporated into the ICP-OES instrument and hence the 
characteristic wavelength of released visible or ultraviolet radiation is isolated, 
transduced (photomultiplied) and computed into a signal characteristic of that specific 
element. The typical source of heat energy used in ICP-OES is an argon torch which 
consists of three concentric quartz tubes through which argon gas tangentially flows. 
Magnetic induction results in a magnetic field which causes the ions and electrons to flow 
in a closed annular path. The resistance of the ions and electrons to this flow of charge 
causes ohmic heating of the plasma. Temperatures of 8000 K are reached within the 
argon plasma core. After heating of the plasma, the sample is introduced in the form of a 
fine mist or aerosol. The conversion of the liquid sample into a suspension of finely 
divided liquid or solid particles in a gas (aerosol) is carried out with the use of a 
nebulizer. Thus, the excitation of the sample atoms is achieved and a characteristic 
emission signal is detected [101]. 
The analysis of each sample was carried out on a Perkin Elmer Optima 5300 DV 
Spectrometer. Calibration of the instrument was conducted using a mixed metal standard 
solution. A mixed metal stock solution was prepared using nitrate metal precursors of 
magnesium, aluminum, zinc and iron. Zinc and iron salts were purchased from Merck 
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Chemicals, Gauteng, R.S.A. The stock solution was made up in 1 litre of double distilled 
water to a final concentration of 100 ppm. A series of mixed metal standard solutions 
with concentrations of 0.25 ppm, 0.5 ppm, 1.5 ppm, 3 ppm and 5 ppm were prepared 
using the stock solution for calibration. For sample analysis, approximately 0.01 g of 
finely ground, dry product was placed in a 25 ml volumetric flask. To this flask, 
approximately 10 ml of 0.1 M HNO3 was added in order to digest the powdered product. 
The flasks were heated in some cases to aid digestion. The digested solution was made up 
to the mark with double distilled water. Approximately 10 ml of this solution was then 
transferred to a 15 ml centrifuge tube and set aside for ICP-OES analysis. Each standard 
and sample solution was done in triplicate.  
 
2.1.3.2 Powder X-ray diffraction (XRD) 
 
Powder XRD remains an essential tool in the characterization of many materials. 
Although single crystal analysis remains the technique of choice for the analysis of 
crystal structures, the size and quality of single crystals of a material often prevent this 
analysis from being utilized. XRD proves to be an excellent alternative in the above case, 
in which the crystal structure, lattice parameters, micro and macro strain, crystalline and 
amorphous phases as well as crystal sizes can be elucidated [103]. XRD was first 
described by Bragg and Bragg in 1913, where they developed a relationship to explain 
the reflection of X-ray beams on the faces of crystals at certain angles of incidence. This 
relationship is expressed as the Bragg equation, nλ=2dsinθ, where n is an integer, λ is the 
wavelength of the incident X-ray beam, d is the distance between atomic layers in a 
crystal and θ is the diffraction angle. The reflection of the incident beam of X-rays by the 
atomic planes of a crystal is due to the constructive interference of the X-rays entering 
the material which results in the observed diffraction pattern (Figure 2.2). This 
phenomenon is termed X-ray diffraction. 
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Figure 2.2 Diffraction of incident X-rays according to Bragg (Redrawn and adapted from 
[103]). 
 
The Bragg analysis depicts X-rays like visible light being reflected by the surface of a 
mirror, with X-rays being reflected at lattice planes. Lattice planes are crystallographic 
planes, portrayed by Miller indices (hkl). Parallel planes also present in the crystal 
structure, have identical indices and are separated by the distance d(hkl). X-rays penetrate 
through the material resulting in reflections due to crystal faces as well as additional 
reflections due to numerous other parallel planes. Thus, as the diffracted X-rays travel in 
the same direction with respect to the atomic plane, superposition of the scattered rays 
occurs. Bragg’s equation is only satisfied for constructive interference of X-rays 1 and 2. 
In reality, the X-rays are not reflected and are infact scattered by electrons bound to the 
atoms as indicated as solid black circles on Figure 2.2. Both the Bragg equation and 
expressions of the Bragg equation can be derived from calculations based upon the 
geometry of the scattering taking place at the position of atoms in consecutive planes as 
well as the energy associated with the X-rays [103]. Analysis software accompanying 
XRD instrumentation computes diffraction patterns in relation to intensity of the 
diffracted X-rays. 
All samples were analyzed directly on a Bruker D8 Advance XRD (CuKα radiation), 
using Bruker analysis software. A mass of approximately 0.5 g was used in each case. 
The scan-speed was set to 0.5 seconds for all samples, with a total analysis time of 40-50 










2.1.3.3 Fourier transform infrared (FTIR) spectroscopy 
 
The basic modes of motion namely, translation, vibration and rotation of a molecule 
indicate the ways in which a molecule may store energy. The transitions between 
different energy states can be observed spectroscopically [104]. Fourier transform 
infrared (FTIR) spectroscopy is based upon the measurement of the wavelength and 
intensity of the absorption of infrared light by a molecule. Due to this absorption, 
molecules within a sample may undergo vibrational, bending or rotational modes. Thus, 
each type of chemical bond exhibits a specific IR absorption band at a characteristic 
wavelength. Spectroscopic methods such as ultra-violet (UV) or visible spectroscopy rely 
on the use of a monochromator or filter to isolate the desired wavelength band so that 
only the band of interest is detected and measured [102]. FTIR spectroscopy is unique in 
that it contains an interferometer in place of a monochromator that produces interference 
patterns which contain the infrared spectral data. In addition, FTIR detectors are able to 
detect all wavelengths continuously. Thus, based upon the characteristic modes of motion 
of bonds at characteristic wavelengths, FTIR is able to compute the radiant power 
produced as a function of wavelength, as the source signal is modulated by the 
interferometer to produce an absorption spectrum of the sample. Most interferometers 
compute absorption spectra of molecules in relation to interference patterns from a 
background (solvent, ambient water and CO2) spectrum [102]. In this study, attenuated 
total reflection-fourier transform infrared spectroscopy (ATR-FTIR) was employed. 
ATR-FTIR operates by measuring the changes that occur in a totally internally reflected 
infrared beam when the beam comes in contact with a sample. An infrared is first passed 
through a dense crystal with a high refractive index. The beam undergoes internal 
reflectance within the crystal and creates an evanescent wave that extends beyond the 
surface of the crystal and penetrates the sample. Where the sample absorbs energy, the 
evanescent wave will be attenuated or altered. The attenuated or altered energy from each 
evanescent wave re-enters into the infrared beam which exits the opposite end of the 
crystal and enters into a detector. The ATR-FTIR system then produces an infrared 
spectrum [105]. 
All samples were analyzed directly on a Perkin Elmer Spectrum Universal ATR 100 FT-
IR Spectrometer. Prior to sample analysis, the crystal area was cleaned and the 
background collected. Approximately 0.4 g of each product (dry, finely ground) was 
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placed over the surface of the crystal and the pressure arm locked into place. The spectra 
were then collected. 
 
2.1.3.4 Raman spectroscopy 
 
Raman spectroscopy is based upon the observations of a change in frequency when light 
is scattered by molecules [106]. The scattering of light was first observed in 1982 by 
Raman and Kishnan. Since then, the measurement of light scattering has been referred to 
Raman spectroscopy [107]. The change of frequency of light which can be related to an 
equivalent energy change. This change in frequency is the result of the difference 
between incident light with a frequency, v0 and scattered light with a frequency vs. Raman 
spectroscopy is often used in conjunction with FTIR spectroscopy since both these 
techniques give a better analysis of the vibrational structure of a molecule.  
For analysis, each sample was placed in a clear shell vial (VWR International, West 
Chester, PA), approximately 5 mm from the base of the vial. The shell vial was then 
sealed and gently tapped at an angle, causing the sample to lie at an angle sloping 
upwards. The shell vial was then placed into the sample holder on a DeltaNu Advantage 
532 Raman Spectrometer. Raman analysis was performed on each sample and spectra 
captured using NuSpecTM software and spectra analysis using GRAMS/AI spectroscopy 
software suite 9.00 R2.  
 
2.1.3.5 Transmission electron microscopy (TEM) 
 
Electron microscopy is routinely used in the characterization of various compounds, 
including HTs and LDHs. Electron microscopy utilizes electrons in a very similar way to 
that of light in microscopes and makes use of a source of illumination (electron gun), 
condenser lenses (electromagnetic lenses) and an imaging system. In order to produce 
high resolution images of the sample, a focused beam of electrons produced by an 
electron gun is directed onto the sample. The electron gun consists of a tungsten filament 
surrounded by a cone-shaped Wehnelt cylinder shield except for the tip which is exposed 
to an anode. Upon heating of the tungsten filament to high temperatures (>2700oC), 
electrons are ejected from the tip of tungsten filament, forming a diverging beam. 
Thereafter, a high negative voltage is applied to the Wehnelt cylinder creating a large 
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potential difference between this highly negatively charged Wehnelt cylinder and the 
positive anode. This potential difference forces the attraction of the electrons from the tip 
of the tungsten filament towards the anode. With the presence of electromagnetic lenses, 
this stream of electrons is focused into a beam, which is further directed towards the 
sample. 
Transmission electron microscopy (TEM) is utilized in order to study the interior and 
exterior surfaces of a sample. Samples are thinly sliced or placed directly into a copper 
grid sample holder and subjected to the striking of the sample by the electron beam 
resulting in the formation of an image. Images formed in TEM result in changes in 
direction of electrons penetrating the sample creating a contrasting image, i.e., electrons 
that strike a denser area of the sample will not pass through the sample and will thus be 
scattered, depicted as a darker area on the TEM image. However, electrons that strike a 
translucent or less dense area of the sample will pass through the sample, thus appearing 
as a light area on the image. Thus images of varying brightness are formed. 
All samples were viewed using a JEOL 1010 Megaview 3 Soft Imaging TEM System, 
employing iTEM software. For TEM analysis, approximately 0.001 g of finely ground, 
dry HT or LDH material was suspended in approximately 5 ml of absolute alcohol 
(Merck Chemicals, Gauteng, R.S.A.) and sonicated for 20 minutes. Thereafter, 1 μl of 
each sample was placed onto a copper grid. The copper grids were then air-dried and 
viewed. 
 
2.1.3.6 Scanning electron microscopy (SEM) and scanning electron microscopy- 
energy dispersive X-ray spectrometry (SEM-EDX) 
 
Scanning electron microscopy (SEM) is utilized in order to study the surface areas of the 
sample and makes use of a focused spot of electrons (probe) that scans the surface of the 
sample. The formation of an image using SEM relates to the interactions that these 
electrons have on the surface of the sample. These electrons will deflect at different 
angles according to the angles forming at the surface of the actual sample. These 
deflected electrons which are referred to as secondary electrons are analyzed by a 
detector. The electrons that strike the surface of the sample which are deflected straight 
into the detector will appear as bright areas on the SEM image and those electrons that 
 27 
deflect away from the detector will therefore appear as dark areas of the image. Thus, the 
SEM image formed is a representation of the different deflection patterns of electrons. 
In addition to obtaining images, the chemical or elemental analysis of the surface of a 
sample can be determined. This type of spectroscopy is related to the fact that every 
element has a distinct atomic structure and X-ray pattern when irradiated with charged 
particles such as electrons. Atoms at rest contain ground state electrons which upon 
irradiation with charged electrons results in the promotion of some of these ground state 
electrons to higher energy level orbitals. Therefore, an orbital vacancy now exists 
resulting in electrons from higher energy level orbitals to fill these vacancies. This 
change in energy levels of electrons causes an emittance of characteristic X-rays. The 
number of X-rays, as well as the energy associated with these X-rays is detected by an 
energy dispersive spectrometer (EDS/X). The exact elemental surface composition of that 
sample is obtained. 
For sample analysis, a strip of double sided carbon tape (Nisshin EM, CO. LTD) was 
placed onto a SEM stud. Thereafter, each sample was placed onto this stud and carbon 
coated using a JEOL JEE-4C Vacuum Evaporator. The stud was placed in a LEO 1450 
SEM, using SmartSEM software version 5.03.05. For SEM-EDX, a JEOL JSM-6100 
Scanning Microscope was used equipped with Bruker Espirit software, version 1.9. 
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2.2 Results and discussion 
 
2.2.1 HT and LDH physical properties 
 
The synthesized HTs (Mg-Al) were white powders and LDHs, Zn-Al, Zn-Fe and Mg-Fe 
were white, cream-orange and orange-rust powders respectively. All the samples were 
pliable but not elastic and smooth in texture. Varying degrees of solubilities were 





The results of elemental analysis are shown in Table 2.4. The measured MII:MIII values 
were similar to that of the calculated values for Mg-Al HTs and Zn-Fe LDHs only.  
 
Table 2.4 ICP-OES data for Mg-Al HTs, Zn-Al, Zn-Fe and Mg-Fe LDHs 
Compound Stoichiometry (x) 
MII : MIII 
Calculated Measured 
Mg-Al HT 0.25    3 :1 2.9 :1 
 0.30 2.3 :1 2.2 :1 
 0.33    2 :1 1.9 :1 
    
Zn-Al LDH 0.11    3 :1 8.0 :1 
 0.14 2.3 :1 6.3 : 1 
 0.16    2:1 5.4 :1 
    
Zn-Fe LDH 0.25    3 :1 3.1 :1 
 0.30 2.3 :1 2.3 :1 
 0.33    2 :1 2.1 :1 
    
Mg-Fe LDH 0.55    3 :1 0.8 :1 
 0.58 2.3 :1 0.7 :1 
 0.62    2 :1 0.6 :1 
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The Mg:Fe values showed a range of 0.6-0.8:1 (Mg:Fe). There is a fairly equal 
distribution of both cations within the brucite-like layers and this could be attributed to 
the fact that these cations have very similar ionic radii (Mg2+= 0.65 Å, Fe3+= 0.64 Å). 
Hence, it is possible that the two cations would position themselves fairly evenly 
throughout metal positions within the brucite-like layer. Zn-Al LDH samples, on the 
other hand, showed a greater amount of Zn with x being lower than calculated. According 
to Rojas Delgado et al. [108], Zn-Al LDHs can be obtained with MII:MIII values ranging 
from 1-5 (i.e. 1:1-5:1 MII:MIII). They observe that higher values are due to electrostatic 
repulsion between trivalent metals. However, too high MII:MIII values result in a collapse 
of the interlayer region as they are less populated by charge compensation anions. Here, 
an increase in the value of x is due to greater substitution of Zn2+ by Al3+ within the 
brucite-like layer, which increases the electrostatic attraction between the brucite-like 
layers and the interlayer anions. This attraction results in a compression of the LDH 
structure. In addition, the increasing amounts of Al3+ within the brucite-layer results in 
greater repulsion of neighbouring Al3+ ions [41]. The samples prepared in this study 
showed greater amounts of zinc. This could be the result of the repulsion of trivalent Al, 
leaving vacant positions within the brucite-like layer for Zn2+ to fill. 
 
2.2.2.2 Powder XRD 
 
In general, XRD diffractograms for hydrotalcite show sharp, symmetric and intense lines 
at low 2θ values and less intense and generally asymmetric lines at higher 2θ values [37]. 
The sharp intense lines are indicative of a well ordered crystalline material. Also 
distinctive of an XRD diffractogram for hydrotalcite is a doublet peak at a 2θ value of 60o 
which is indicative of an ordered layered material. Figure 2.3 displays the diffractograms 
of the synthesized HT materials with different x values. All HT samples showed d-
spacing values and peaks ( ) at corresponding 2θ values almost identical to that 
indicated JCPDS file No. 14-191. Both Zn-Fe and Mg-Fe XRD patterns exhibit a 
prominent, heightened non-smooth baseline and hence the minor peaks are not that 
apparent. Most of the LDH samples exhibited XRD patterns similar to that of hydrotalcite 
with the exception of XRD patterns for Zn-Fe LDH samples. In addition, all Mg-Al, Zn-
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Al and Mg-Fe XRD data and patterns are consistent with literature findings [1, 6, 38, 
111]. The d-spacing values for all HT and LDH samples are shown in the appendix 
(Table A3).  
 
Figure 2.3 Powder X-ray diffraction patterns of (a) MgAl.26, (b) MgAl.31,  
and (c) MgAl.34. 
 
Figure 2.4 Powder X-ray diffraction patterns of (a) ZnAl.11, (b) ZnAl.14,  
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Figure 2.5 Powder X-ray diffraction patterns of (a) MgFe.55, (b) MgFe.58,  
and (c) MgFe.62. 
 
The XRD patterns for synthesized Zn-Fe LDHs (Figure 2.6) exhibit a very similar pattern 
to the experimental results of Zhang et al. [109]. Also, the XRD pattern suggests that the 
materials are slightly amorphous with extremely small crystallites. Crystallite sizes for 
Zn-Al LDHs are the largest of the prepared samples, followed by Mg-Fe LDHs and Mg-
Al LDHs. There appears to be no specific trend in relation to increasing or decreasing 
values of x. The crystallite sizes of each HT and LDH synthesized in this study are shown 
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Figure 2.6 Powder X-ray diffraction patterns of (a) ZnFe.24, (b) ZnFe.30,  
and (c) ZnFe.32. 
 
2.5 Crystallite sizes of HTs and LDHs. 
 
aCalculated using the Scherrer’s equation, FWHM values shown in Table A4, Appendix. 
Compound Stoichiometry (x)  Crystallite sizea / nm 
MgAl.25 0.25 1.64 
MgAl.30 0.30 1.65 
MgAl.33 0.33 2.51 
ZnAl.11 0.11 5.38 
ZnAl.14 0.14 5.16 
ZnAl.16 0.16 5.27 
ZnFe.25 0.25 1.69 
ZnFe.30 0.30 1.66 
ZnFe.33 0.33 1.66 
MgFe.55 0.55 2.19 
MgFe.58 0.58 1.78 
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The FTIR spectrum of Mg-Al HT samples are shown in Figure 2.7. The spectra for all 
Mg-Al HT samples exhibit a band at around 410-415 cm-1 and 440-456 cm-1 which can 
be ascribed to Mg-OH translation modes [35, 110]. A single band observed in the 380-
390 cm-1 region is due to O-Al-O vibrational modes. Bands found at 640-650 cm-1 and 





Figure 2.7 FTIR patterns of (a) MgAl.26, (b) MgAl.31, and (c) MgAl.34. 
 
According to Panda et al. [110], the bands at 550 and 660 cm-1 have a tendency to overlap 
and hence the appearance as a broader single peak (Figure 2.7(c)). In addition to Mg-Al-
O modes at around 730 cm-1, an overlap of the anti-symmetric v4 vibration of CO32- is 
also expected [110, 111]. A very weak broad band is observed at around 850 cm-1 (Figure 
2.7, (a) and (c)) which is assigned vibrational modes v2 of CO32- [111]. For Figure 2.7(b), 
this band appears at 920 cm-1. The weak band observed at 1002-1050 cm-1 is due to the v1 































mode of CO32- [1]. The appearance of the v1 mode of CO32- is due to a lowering of 
symmetry of the anion and according to Miyata [6] this is due to the coordination of the 
carbonate anion within the interlayer. The carbonate anion can exist as a monodentate or 
bidentate complex [1, 42]. The strong band at around 1360 cm-1 is associated with anti-
symmetric v3 vibration of CO32- [1, 110, 111]. The weak broad band at 1560-1630 cm-1 is 
due to the bending mode of interlayer water molecules. According to Xie et al. [112] the 
weak bands observed at 2020-2050 cm-1 can be ascribed to adsorbed CO2. A broad band 
at about 3410-3460 cm-1 is due to the stretching of the O-H group of the interlayer water 
molecules [110], the twisting vibrations of physisorbed water, vibrations of hydroxyl 
groups within the brucite-like layer, characteristic valency vibrations of OH·· ·OH, and/or 
characteristic stretching vibrations of metal-OH [35]. A weaker shoulder on this peak is 
observed at around 2900-3000 cm-1 which is ascribed as water-carbonate hydrogen 
bonding within the interlayer region, also describes as the bridging mode of water and 
carbonate [35, 110, 111]. As observed from the spectra the broad band at about 3410-
3460 cm-1 shift towards lower frequencies from spectrum (a) to (c) in Figure 2.7. 
According to Panda et al. [110], upon increasing the Mg ion concentration, this band 
shifts towards higher frequencies which indicates a reduction in the covalency of the 
metal-O interaction. This is due to the electronegativity of the Mg ion being less than that 
of the Al ions which increases the mean metal-O distance, hence decreasing the 












The FTIR spectrum of Zn-Al LDH, Zn-Fe and Mg-Fe samples are displayed in Figure 
2.8-2.10.  

















Figure 2.8 FTIR patterns of (a) ZnAl.11, (b) ZnAl.14, and (c) ZnAl.16. 
 

































































Figure 2.10 FTIR patterns of (a) MgFe.55, (b) MgFe.58, and (c) MgFe.62. 
 
The spectra for all Zn-Al, Zn-Fe and Mg-Fe LDH samples exhibit similar patterns to that 
of Mg-Al HT samples. Bands below 800 cm-1 are assigned to metal-OH translation 
modes. The strong band at around 1360 cm-1 is associated with anti-symmetric v3 
vibration of CO32-. This band is seen as a doublet in Figures 2.8(a), 2.9(a, b and c) and 
2.10(a) at around 1500-1502 cm-1 and 1387-1389 cm-1 respectively. This doublet is 
attributed to a lowering of the symmetry of the carbonate (v3 anti-symmetric vibration 
modes) as well as an indication of the disordered nature of the interlayer [1]. Perhaps the 
disordered nature of the interlayer may cause a destabilization in the layered structure. 
The weak bands observed at 2020-2050 cm-1 can be ascribed to adsorbed or trapped CO2 
within the interlayer region [113]. These bands are not evident in Figure 2.10. A broad 
band seen at 3401-3405 cm-1 is due to the stretching of the O-H groups which are 
hydrogen bonded to the interlayer water molecules [110, 111]. A weaker shoulder on this 
peak is observed at around 2900-3000 cm-1 which is ascribed as the bridging mode of 





















2.2.2.4 Raman spectroscopy. 
 
Figure 2.11 displays the Raman spectra for MgAl.26 HT. The other spectra for Mg-Al 
HTs are shown in the appendix. The spectra for Mg-Al HT samples exhibit a strong 
broad bands at around 400-480 cm-1 which are associated with linkage oxygen bonds of 
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Figure 2.11 Raman spectrum of MgAl.26. 
 
A weak band appears at 800-830 cm-1 is due to the v1 vibrational mode of CO32- 
interacting with the hydroxyl groups of the brucite-like layer. A weaker band at around 
1050 cm-1 could be attributed to the v1 vibrational mode of CO32-. A slightly stronger 
band is observed in the 2400 cm-1 due to weak v1 vibrational modes of adsorbed CO2 
interacting weakly with the interlayer region. For Mg-Al HT samples it appears that upon 
the increase of x, more Mg2+ is substituted by Al3+ which increases the electrostatic 
attraction between the brucite-like layer and interlayer anions [41]. This electrostatic 
compression of the LDH structure would thus result in stronger bonding of the adsorbed 
CO2 and CO32- anions and hence the intensity of the Raman bands thus increases from 
MgAl.26 to MgAl.34. With the increase in bonding, there appears to be a slight decrease 
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in the d(003)-spacing value. In addition, the band assigned as the anti-symmetric v3 
vibration of CO32- (1360 cm-1) increases in the sharpness with an increase in the value of 
x. This further compliments stronger bonding between the adsorbed CO2 and CO32- 
anions. The Raman spectrum for MgAl.31 (Appendix, Figure A3) shows similar features 
to that of MgAl.26. Additional bands for MgAl.31 are observed between 1050-1060 cm-1 
which may be assigned to the v1 vibrational mode of CO32-. Further bands for MgAl.34 
are seen between 1490-1530 cm-1 and these are due to the bending of water and carbonate 
bridges. A peak at around 1700 cm-1 could be due to water deformation modes [111].  
 
The Raman spectra for ZnAl.11, ZnFe.24 and MgFe.55 are shown in Figures 2.12-2.14. 
All other Raman spectra for Zn-Al, Zn-Fe and Mg-Fe LDHs are shown in the appendix. 
From Figures 2.12-2.14, it can be observed that all the materials exibit similar spectra to 
that of Mg-Al HTs. A strong band exists between 420-500 cm-1 which may be associated 







 500  1000  1500  2000  2500  3000 
Intensity / Wavenumber (cm-1) Paged   X-Zoom SCROLL
File # 6 = BB225  9/7/2010  1:07 PM  Res=low








 500  1000  1500  2000  2500  3000 
Intensity / Wavenumber (cm-1) Paged   X-Zoom SCROLL
File # 9 : SMOOTH  9/7/2010  1:18 PM  Res=low
 






 500  1000  1500  2000  2500  3000 
Intensity / Wavenumber (cm-1) Paged   X-Zoom CURSOR
File # 2 = BB425  9/7/2010  1:22 PM  Res=low
Figure 2.14 Raman spectrum of MgFe.55. 
 
The band between 750-800 cm-1 is assigned to the v1 vibrational modes of CO32- 
interactions with hydroxyl groups from the brucite-like layer. 
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In some spectra (Figures A4, A6, and A9, Appendix) there is a strong band at band at 
1050 cm-1 which is assigned as v1 vibrational modes of CO32-. For MgFe.55 (Figure 
2.14), two appear at 1050 cm-1 and 1110 cm-1. The first band is due to symmetric 
stretching of CO32- which is either bonded to external water molecules or the hydroxyl 
groups of the brucite-like external surface and the second band is due to CO32- that is 
interlayer bound [114]. A band at 2400 cm-1 due to adsorbed CO2 increases intensity for 
some samples (Figures A3, A4, A6, A9 and A10, Appendix). This increase in intensity 
results in a decrease in the d(003)-spacing value. This band at 2400 cm-1 is not evident in 


























Figure 2.15 shows the TEM images of all Mg-Al HT samples. The Mg-Al HT samples 
were noted to be fairly translucent in nature. The particle morphology ranged from round 
to hexagonal to irregular and was consistent with literature findings [25-28]. 
 
 
                                    
Figure 2.15 TEM images of (a) MgAl.26 (x200k), (b) MgAl.31 (x200k),  
and (c) MgAl.34 (x200k). 
 
Short darker rod-like particles are seen overlapping one another and these are attributed 
to the LDHs residing in the side on position opposite to the direct plane of view. Using 
iTem software particle width and lateral size may be measured. The particle width of rod-
like particles ranged from 5-15 nm. The particle lateral size range for Mg-Al HT samples 









        
 
Figure 2.16 TEM images of (a) ZnAl.11 (x60k), (b) ZnAl.14 (x75k),  
and (c) ZnAl.16 (x75k). 
 
The particle morphology of the Zn-Al LDH samples ranged from irregular to hexagonal 
with these particles appearing much denser than Mg-Al HT samples, although they 
appeared slightly translucent (Figure 2.16). The particles lying on their side were much 
wider than Mg-Al HT samples, with widths ranging from 50-70 nm. The particle size 
range was 80-320 nm with a mean size of 220 nm, SD ± 13 nm (n = 3). 
 
Figure 2.17 shows the TEM images of all Mg-Fe LDH samples. The particle morphology 
ranged from round to irregular and resembled those of Mg-Al HT samples. The particles 
lying on their side had a width ranging from 5-15 nm. The particle size range was 20-400 
nm with a mean size range of 100 nm, SD ± 23 nm (n = 3). These Mg-Fe LDH samples 
were also translucent in nature. 
(a) (b) 
(c) 
500 nm 200 nm 
200 nm 
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Figure 2.17 TEM images of (a) MgFe.55 (x100k), (b) MgFe.58 (x120k),  
and (c) MgFe.62 (x200k). 
 
 
The particle morphology for Zn-Fe LDHs was quite different to that of all the other HT 
and LDH samples (Figure 2.18). From the images, two types of particles existed. The 
small dark circular particles with a size of 5 nm were in abundance. These particles 
aggregated to form larger clumps. The second type of particle was larger in size and 
irregular in shape. The size range of these larger particles was 50 nm-100 nm. Only the 
larger particles appeared translucent. The mean size for the larger particles was 100 nm, 










     
 
Figure 2.18 TEM images of (a) ZnFe.24 (x200k), (b) ZnFe.30 (x200k), and (c) ZnFe.32 
(x200k). 
 
2.2.2.6 SEM, SEM-EDX 
 
The SEM images for all samples are shown in Figures 2.19-2.22. Magnesium-Al HTs, 
Zn-Al LDHs and Zn-Fe LDHs (excluding ZnFe.32, Figure 2.21 (c)) exhibit clusters of 3-
dimensional irregular, hexagonal disk-shaped particles. The SEM images for the ZnFe.32 
LDH sample, showed large ‘globule-like’ clusters which could be clusters of the circular 
particles. The SEM image of ZnAl.14 shows two unknown ‘rod-like’ structures with 
lengths of 2 μm, respectively. Mg-Fe LDH images (Figure 2.22) show large ‘sheet-like’ 
layered material. Irregular shaped smaller particles can also be seen. This layered ‘sheet-




100 nm 100 nm 
100 nm 
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(Figure 2.21 (a) and (b)). This can be attributed to the irregular particles overlapping and 





































Elemental mapping images obtained form SEM-EDX for all samples are displayed in 
Figures 2.23-2.26. The spectra are located in the appendix. From the elemental mapping, 
the distribution of MII to MIII is fairly even with the exception of Zn-Al and Zn-Fe LDHs 
which both show increased amounts of surface zinc. The elemental values MII:MIII are 
reported in Table 2.6.  
 
Table 2.6 SEM-EDX elemental analysis data for each sample. 
Compound Stoichiometry (x) 
MII : MIII 
Calculated Measured 
Mg-Al HT 0.31    3 :1 2.2 :1 
 0.35 2.3 :1 1.8 :1 
 0.4    2 :1 1.5 :1 
    
Zn-Al LDH 0.12    3 :1 6.8 :1 
 0.16 2.3 :1 5.2 : 1 
 0.18    3 :1 4.7 :1 
    
Zn-Fe LDH 0.18    3 :1 4.5 :1 
 0.21 2.3 :1 3.8 :1 
 0.23    2 :1 3.3 :1 
    
Mg-Fe LDH 0.37    3 :1 1.7 :1 
 0.45 2.3 :1 1.2 :1 
 0.50    2 :1 1.0 :1 
 
The measured values were fairly similar with the calculated ones for Mg-Al HTs. The 
values were totally different for Zn-Al, Zn-Fe and Mg-Fe LDHs as expected when 
compared to ICP-OES. The deviation of measured values from the calculated values can 
be expected from SEM-EDX analysis since this technique employs surface elemental 












Figure 2.23 SEM-EDX mapping images of (a), (b) MgAl.26, (c), (d) MgAl.31,  



















Figure 2.24 SEM-EDX mapping images of (a), (b) ZnAl.11, (c), (d) ZnAl.14,  
and (e), (f) ZnAl.16. 
80 μm 
80 μm 














Figure 2.25 SEM-EDX mapping images of (a), (b) ZnFe.24, (c), (d) ZnFe.30,  
and (e), (f) ZnFe.32. 
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Figure 2.26 SEM-EDX mapping images of (a), (b) MgFe.55, (c), (d) MgFe.58,  
and (e), (f) MgFe.62. 
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DNA/NUCLEIC ACID BINDING ASSAYS, IN VITRO, CYTOTOXICITY AND 
TRANSFECTION ASSAYS 
 




Plasmid DNA exists in three forms namely; linear, relaxed closed circular and 
superhelical/supercoiled. In most cases supercoiled and relaxed closed circular forms are 
often found with the linear form being observed less frequently. These different forms of 
plasmid DNA migrate at different rates during agarose gel electrophoresis. 
Superhelical/supercoiled DNA is a highly compacted from of the plasmid. Relaxed 
closed circular is found to be intact yet enzymatically relaxed, i.e. the supercoils from the 
superhelical form have relaxed. The linear form of a plasmid is found to have free ends, 
in which the DNA strands have been enzymatically cleaved in which there are physical 
breaks in phosphodiester bonds. Upon loading of plasmid DNA onto an agarose gel and 
subjecting it to electrophoresis, these different forms will migrate at different rates. Out 
of the three forms described, superhelical DNA, due to its compact form, migrates faster 
through the agarose matrix and thus will appear further down the agarose gel. It is found 
that the linear form of the plasmid migrates slightly slower than the superhelical and will 
thus migrate just before the superhelical form. Lastly the relaxed closed circular form is 
the slowest in migration due to the open circular ring-like form finding difficulty 
migrating through the agarose matrix and thus will appear closer to the point of 
application (agarose well). 
A gel retardation assay is carried out in order to evaluate the extent of DNA binding to a 
specific carrier or vector. With this assay, the concentration of DNA is kept constant and 
the concentration of the vector is successively increased. If a known amount of the carrier 
and DNA are both mixed together appropriately and allowed to migrate through an 
agarose gel and no interaction occurs between the DNA and the vector, the DNA should 
migrate through the gel and the carrier will remain in the well. However if the DNA 
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binds to the carrier, the DNA will not migrate (i.e. retardation of migration) and hence 
will remain in the well bound to the carrier. Thus the successive concentration increase of 
vector results in less free DNA that will migrate into the agarose gel. A point will be 
reached where all of the DNA is vector bound and in the well - thus an optimum binding 
ratio of DNA:vector is determined. The DNA binding is visualized in the gel due to the 
incorporation of a DNA intercalating dye ethidium bromide (EtBr) which fluoresces 
when irradiated with UV light. Thus the appearance of orange bands against a dark 
background allows the exact migration of DNA to be followed under UV light. The 
intercalating agent can be added directly into the agarose gel preparation or the gel can be 
stained post-electrophoresis. The gel is then irradiated with UV light and a photographic 
image captured.  
 
3.1.2 Materials and methods 
 
3.1.2.1 DNA:HT/LDH complexes 
 
Plasmid pCMV-GFP DNA (The Plasmid Factory, Germany. Concentration 1.0 mg / ml 
stock) was kept constant in all samples at 0.5 μg. Each HT and LDH powdered sample 
was made up in 18 mohm water with a final HT/LDH concentration of 10 μg / μl. 
Samples were prepared in 1.5 ml microcentrifuge tubes according to the following Tables 
3.1-3.4. 
 
Table 3.1 Synthesis details for DNA:Mg-Al HT complexes 
Sample Ratio DNA:HT 
Volume (μl) Total Volume 
(μl) pCMV-GFP HT HBS* 
MgAl.26 1:35 1.0 1.8 7.2 10.0 
 1:40 1.0 2.0 7.0 10.0 
 1:50 1.0 2.3 6.7 10.0 
MgAl.31 1:50 1.0 2.5 6.5 10.0 
 1:55 1.0 2,8 6.2 10.0 
 1:60 1.0 3.0 6.0 10.0 
MgAl.34 1:35 1.0 1.8 7.2 10.0 
 1:40 1.0 2.0 7.0 10.0 
 1:45 1.0 2.3 6.7 10.0 
*Prepared Hepes buffered saline (HBS), Hepes (Merck, Darmstadt, Germany). 
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Table 3.2 Synthesis details for DNA:Zn-Al LDH complexes 
Sample Ratio DNA:LDH 
Volume (μl) Total Volume 
(μl) pCMV-GFP LDH HBS* 
ZnAl.11 1:60 1.0 3.0 6.0 10.0 
 1:65 1.0 3.3 5.7 10.0 
 1:70 1.0 3.5 5.5 10.0 
ZnAl.14 1:40 1.0 2.0 7.0 10.0 
 1:45 1.0 2.3 6.7 10.0 
 1:50 1.0 2.5 6.5 10.0 
ZnAl.16 1:40 1.0 2.0 7.0 10.0 
 1:45 1.0 2.3 6.7 10.0 
 1:50 1.0 2.5 6.5 10.0 
*Prepared Hepes buffered saline (HBS), Hepes (Merck, Darmstadt, Germany). 
 
Table 3.3 Synthesis details for DNA:Zn-Fe LDH complexes 
Sample Ratio DNA:LDH 
Volume (μl) Total Volume 
(μl) pCMV-GFP LDH HBS* 
ZnFe.24 1:30 1.0 1.5 7.5 10.0 
 1:35 1.0 1.8 7.2 10.0 
 1:40 1.0 2.0 7.0 10.0 
ZnFe.30 1:30 1.0 1.5 7.5 10.0 
 1:35 1.0 1.8 7.2 10.0 
 1:40 1.0 2.0 7.0 10.0 
ZnFe.32 1:30 1.0 1.5 7.5 10.0 
 1:35 1.0 1.8 7.2 10.0 
 1:40 1.0 2.0 7.0 10.0 
*Prepared Hepes buffered saline (HBS), Hepes (Merck, Darmstadt, Germany). 
 
Table 3.4 Synthesis details for DNA:Mg-Fe LDH complexes 
Sample Ratio DNA:LDH 
Volume (μl) Total Volume 
(μl) pCMV-GFP LDH HBS* 
MgFe.55 1:25 1.0 1.3 7.7 10.0 
 1:30 1.0 1.5 7.5 10.0 
 1:35 1.0 1.8 7.2 10.0 
MgFe.58 1:45 1.0 2.3 6.7 10.0 
 1:50 1.0 2.5 6.5 10.0 
 1:55 1.0 2.8 6.2 10.0 
MgFe.62 1:30 1.0 1.5 7.7 10.0 
 1:35 1.0 1.8 7.5 10.0 
 1:40 1.0 2.0 7.2 10.0 
*Prepared Hepes buffered saline (HBS), Hepes (Merck, Darmstadt, Germany). 
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Samples (Mg-Al HTs, MgFe.55 and MgFe.58) were then incubated at 60oC for 2 hours in 
a Scientific oven. Remaining samples (Zn-Al LDHs, Zn-Fe LDHs and MgFe.62) were 
incubated at 60oC for 72 hours – 72 hours was determined as the required incubation time 
for DNA: LDH complex formation for these samples (in depth discussion on this 
observation indicated in results and discussion). After this incubation time the samples 
were then loaded onto 1% agarose gels and subjected to electrophoresis for 90 minutes at 
50 V. 
 
3.1.2.2 Agarose gel and electrophoresis 
 
Approximately 0.2 g of agarose (Sigma-Aldrich, Steinheim, Germany) was dissolved 
with heating in 18 ml distilled water. The solution was then cooled to approximately 
75oC and 2 ml of 10x electrophoresis buffer (0.36 M Tris-HCl, 0.3 M NaH2PO4 and 0.1 
M EDTA (Merck, Darmstadt, Germany)) was added. This was then followed by the 
addition of 3 μl of ethidium bromide (10 mg/ml). The solution was cooled to 
approximately 60-62oC and poured onto a gel tray with an 8 well comb. This was allowed 
to set for approximately 45-60 minutes. Thereafter, the comb was removed and the tray 
submersed into an electrophoresis unit (Bio-Rad Mini-Sub® Cell GT) containing 1 x 
electrophoresis buffer. 
To each sample, including the standard DNA marker sample, 2 μl of gel loading buffer / 
stop solution (40 % Sucrose, 0.05 % Bromophenol blue). Each gel contained a standard 
in which 10 μl of a HBS buffered solution of DNA (0.5 μg) was loaded onto the agarose 
gel. The incubated samples as per Tables 3.1-3.4 were loaded onto the gel alongside the 
standard and subjected to electrophoresis. After electrophoresis the gel was then removed 
and viewed under UV light using a Syngene G-box documentation system (Vacutec) and 
an image captured.  
 
3.1.2.3 Characterization of DNA:HT binding 
 
Out of the samples prepared, from gel retardation assays, MgAl.31 (1:55) was selected as 
an ideal representative of DNA binding due to its full retardation. The DNA:MgAl.31 
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(1:55) complex was then characterized using TEM, XRD, FTIR and Raman 
spectroscopy. The complex was prepared according to Table 3.1 for TEM analysis. For 
XRD, FTIR and Raman spectroscopy, the preparation of the complex was scaled up to 
10:550 (mg:mg). The complexes were then incubated at 60oC for 2 hours, thereafter 
characterization was carried out 
 
TEM 
The complex was viewed using a Zeiss, Libra 120 TEM, employing Zeiss software. For 
sample analysis, 1 μl of the complex was placed onto a copper grid. The copper grid was 
then air-dried and viewed. 
 
XRD 
Both the complex and DNA-free MgAl.31 were separately analyzed directly on a Bruker 
D8 Advance XRD (CuKα radiation), using Bruker analysis software. Prior to sample 
analysis, the complex was dried in an oven at 60oC for 24 hours. The entire dried 
powdered complex was placed onto the sample holder and gently flattened. The scan-
speed was set to 0.5 seconds. 
 
FTIR 
Both the complex and ‘free’ DNA were separately analyzed directly on a Perkin Elmer 
Spectrum Universal ATR 100 FT-IR Spectrometer. Prior to sample analysis, the complex 
was dried in an oven at 60oC for 24 hours. Thereafter, the intstrument crystal area was 
cleaned and the background collected. Approximately 0.5 g of the dried complex product 
was placed over the surface of the crystal and the pressure arm locked into place. The 
spectra were then collected. 
 
Raman spectroscopy 
Both the complex and DNA-free MgAl.31 were separately analyzed on a DeltaNu 
Advantage 532 Raman Spectrometer. Each sample was placed in a clear shell vial (VWR 
International, West Chester, PA), approximately 5 mm from the base of the vial. The 
shell vial was then sealed and gently tapped at an angle, causing the sample to lie at an 
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angle sloping upwards. The shell vial was then placed into the sample holder and placed 
into the Raman Spectrometer. Raman analysis was performed on each sample and spectra 
captured using NuSpecTM software and spectra analysis using GRAMS/AI spectroscopy 
software suite 9.00 R2.  
 
3.1.3 Results and discussion 
 
The synthesis of the HTs and LDHs in this study was to ascertain if these compounds 
have an application in gene delivery into mammalian cells in culture. Therefore the 
powdered product needed to be in a solution form and hence 18 mohm water was 
utilized. Varying degrees of solubilities were observed for all the samples (Appendix, 
Table A2, Figures A2 and A3). Most of the samples were not soluble in water, with the 
exception of MgFe.55 and MgFe.58 which remained in solution for several months. 
From gel retardation assays, all HT and LDH samples showed the ability to 
electrostatically bind DNA at varying degrees. As discussed in chapter two, HTs and 
LDHs exhibit an anion interlayer that is able to undergo ion-exchange. Many authors 
have exploited this property giving rise to a wide variety of applications such as the 
removal of toxic anions and herbicides from water and the ion exchange of various 
pharmaceuticals and biomolecules, including the intercalation of DNA [58, 81]. 
In the formation of the DNA:HT/LDH complexes; ion exchange reactions were explored. 
Investigators using similar Mg-Al HT materials have used varying temperatures and 
incubation times such as; 48 hours at 60oC [71], 30 minutes at 37oC [115], 4 hours 
(involving light shaking) at 37oC [27], 15 minutes (involving light shaking) at 60oC [28], 
12 hours at 37oC [116]. All of these methods were attempted in this study; with 
incubation temperatures done at 37oC and 60oC for 15 minutes giving unsatisfactory 
results. However longer incubation times at 60oC showed the successful formation of 
DNA:HT/LDH complexes that was confirmed by gel retardation. A time dependent 
incubation (30 minutes-72 hours) at 60oC was carried out (data not shown) on all samples 
and it was observed that DNA had been bound by Mg-Al HTs, MgFe.55, MgFe.58 
samples after 1 ½ hours incubation (<1 ½ hours, DNA was partially retarded) confirmed 
by gel retardation assays. Subsequent reactions were then carried out at 60oC for 2 hours 
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for Mg-Al HTs, MgFe.55, MgFe.58 samples. All Zn-Al LDH, Zn-Fe LDH, MgAl.26 and 
MgFe.62 samples seemed to show a similar trend of incomplete binding of DNA while 
much of the DNA was seen to migrate into the gel. From the time dependent incubation it 
appeared that 72 hours resulted in more DNA being bound to the Zn-Al and Zn-Fe LDH 
samples (Figure 3.1). Subsequent reactions were then carried out at 60oC for 72 hours for 
Zn-Al LDHs, Zn-Fe LDHs and MgFe.62 samples. 
 
     
(60oC, 24 hours)                 (60oC, 48 hours)               (60oC, 72 hours) 
Figure 3.1 Gel Retardation Assay of Zn-Al and Zn-Fe LDHs 
Lane 1       = pCMV-GFP (0.5 μg) 
Lane 2, 8, 14   = 1:65 ZnAl.11  
Lane 3, 9, 15   = 1:45 ZnAl.14 
Lane 4, 10       = 1:45 ZnAl.16 
Lane 5, 11, 16 = 1:35 ZnFe.24 
Lane 6, 12, 17 = 1:35 ZnFe.30 
Lane 7, 13       = 1:35 ZnFe.33 
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From Figure 3.2, MgAl.26 partially retarded the DNA. i.e. the compound was able to 
bind some of the DNA in solution. The bound DNA remained in the well viewed as an 
orange band (under UV light) within the well. The unbound DNA in samples MgAl.26 is 
thus able to migrate as free DNA and hence resembles the standard DNA (lane one) with 
the appearance of orange bands (superhelical and closed circular forms visible). The ratio 
of DNA (μg): MgAl.26 (μg) was increased up to 1:155 so as to ascertain if more HT was 
required to bind the free DNA, however to no avail. MgAl.31 and MgAl.34 on the other 
hand, showed complete retardation at ratios 1:50 and 1:45 respectively. 
        
Figure 3.2 Gel Retardation Assay of Mg-Al HTs. 
    Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = 1:35 MgAl.26 
Lane 3 = 1:40 MgAl.26 
Lane 4 = 1:45 MgAl.26 
Lane 5 = 1:50 MgAl.31 
Lane 6 = 1:55 MgAl.31 
Lane 7 = 1:60 MgAl.31 
Lane 8 = 1:35 MgAl.34 
Lane 9 = 1:40 MgAl.34 
Lane 10 = 1:45 MgAl.34. 
DNA was kept constant at 0.5 μg. 
 1        2        3       4       5        6        7      1           8   9   10 
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All Zn-Al LDH samples (Figure 3.3) showed very little binding ability, with more 
unbound DNA than bound DNA (very faint bands in well visible). Higher ratios up to 
1:155 were carried are for all Zn-Al LDH samples, with no change in their retardation 
pattern and hence no change in their DNA binding ability. Interesting to note that the 
band of supercoiled DNA (i.e. the band that migrates the furthest into the gel) has been 
bound by the Zn-Al LDHs with the other forms of DNA remaining in solution. This is 
confirmed by the absence of the supercoiled band compared to the standard DNA. 
 
   
Figure 3.3 Gel Retardation Assay of Zn-Al LDHs. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = 1:60 ZnAl.11 
Lane 3 = 1:65 ZnAl.11 
Lane 4 = 1:70 ZnAl.11 
Lane 5 = 1:40 ZnAl.14 
Lane 6 = 1:45 ZnAl.14 
Lane 7 = 1:50 ZnAl.14 
Lane 8 = 1:40 ZnAl.16 
Lane 9 = 1:45 ZnAl.16 
Lane 10 = 1:50 ZnAl.16 
DNA was kept constant at 0.5 μg. 
 
 
 1                     2    3    4                       1      5      6      7        1        8        9      10 
 63 
A similar pattern was seen for Zn-Fe LDH samples (Figure 3.4), in which partial 
retardation was observed. Higher ratios of 1:155 were carried are for all Zn-Fe samples 
yet there was no change in their retardation pattern. Zn-Fe LDH samples also appeared to 
bind supercoiled DNA, with the exception of ZnFe.30 (Figure 3.4, lanes 5, 6, 7) in which 
the band of supercoiled DNA is evident. Thus both Zn-Al and Zn-Fe LDHs appear to 
have a selectivity for supercoiled DNA. 
 
   
Figure 3.4 Gel Retardation Assay of Zn-Fe LDHs. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = 1:30 ZnFe.24 
Lane 3 = 1:35 ZnFe.24 
Lane 4 = 1:40 ZnFe.24 
Lane 5 = 1:30 ZnFe.30 
Lane 6 = 1:35 ZnFe.30 
Lane 7 = 1:40 ZnFe.30 
Lane 8 = 1:30 ZnFe.32 
Lane 9 = 1:35 ZnFe.32 
Lane 10 = 1:40 ZnFe.32 
DNA was kept constant at 0.5 μg for lanes 1-4, 8-10 and 
1.0 μg for lanes 5-7. 
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MgFe.55 and MgFe.58 (Figure 3.5) showed full retardation at about 1:30 (Lane 3) and 
1:50 (Lane 5) respectively. MgFe.62 showed partial retardation, with more bound DNA 
seen in the well than unbound DNA. The gel retardation pattern of MgFe.62 was similar 
to that of Zn-Al and Zn-Fe samples. Thus the ion exchange conditions for these samples 
was re-evaluated and through a time dependent gel retardation the optimum incubation 
time was determined as 72 hours. Figure 3.1 shows improved DNA retardation, however 
streaking is observed right the way down the gel which is attributed to DNA degradation, 
this could be due to prolonged incubation at 60oC or the HT / LDH itself is causing DNA 
degradation. Some DNA degradation was also observed for other Mg-Fe LDH samples. 
 
   
Figure 3.5 Gel Retardation Assay of Mg-Fe LDHs. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = 1:20 MgFe.55 
Lane 3 = 1:30 MgFe.55 
Lane 4 = 1:40 MgFe.58 
Lane 5 = 1:50 MgFe.58 
Lane 6 = 1:30 MgFe.62 
Lane 7 = 1:40 MgFe.62 
DNA was kept constant at 0.5 μg. 
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From these results, it can be seen that the HT and LDH samples showed varying degrees 
of DNA binding. For gene delivery studies, it is often advisable - as a rule of thumb- to 
take the successive ratio below and above the optimum binding ratio, since, although the 
optimum binding ratio is the ratio at which DNA is optimally bound, the successive ratio 
above or below could perhaps be more efficient in gene delivery (transfection) in vitro 
and extended to in vivo studies. This is due to the fact that, during complex formation of 
the DNA to the compound used, a successive ratio below may in fact electrostatically 
bind the DNA loosely due to lower amounts of the compound and may release DNA 
more easily than that of the optimum ratio which could perhaps bind the DNA very 
tightly thus decreasing the amount of DNA being released within the cell. In addition, as 
one is working with a biological system, the nature of the compound itself may govern 
the efficiency in which transfection occurs. Thus from the successive ratios used, one is 
then able to select the most efficient ratio in order to develop that particular ratio into in 
vivo studies. The optimum binding ratio (shown as bold) as well as the successive ratio 
below and above are reported below. 
 
  Table 3.5 DNA:HT/LDH ratios. 
Sample DNA:HT/LDH (μg:μg) 
MgAl.26 1:35, 1:40, 1:45 
MgAl.31 1:50, 1:55, 1:60 
MgAl.34 1:35, 1:40, 1:45 
ZnAl.11 1:60, 1:65, 1:70 
ZnAl.14 1:40, 1:45, 1:50 
ZnAl.16 1:40, 1:45, 1:50 
ZnFe.24 1:30, 1:35, 1:40 
ZnFe.30 1:30, 1:35, 1:40 
ZnFe.32 1:30, 1:35, 1:40 
MgFe.55 1:25, 1:30, 1:35 
MgFe.58 1:45, 1:50, 1:55 
MgFe.62 1:30, 1:35, 1:40 
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Previous studies using Mg-Al HTs in the delivery of oligonucleotides and DNA [15-17, 
76, 78] indicated the mechanism of DNA binding was due to ion exchange of the 
interlayer anions. Thus the possible mechanism of DNA binding was evaluated in this 
study. XRD, FTIR, TEM and Raman spectroscopy were used in the evaluation of the 
binding mechanism of DNA:HT/LDH samples.  
Out of the samples prepared, from gel retardation, MgAl.31 (1:55) was selected as an 
ideal representative of DNA binding due to its full retardation. From XRD patterns of 
MgAl.31 (Figure 3.6), no change in the XRD diffractogram or d-spacing values was 
observed (Fig. 3.6(a) versus b), in addition, if DNA was intercalated within the interlayer, 
a peak at about a 2-theta value of about 5-9o with a value of 23.7 Å should have been 
observed [88], since the diameter of DNA is 23.7 Å [116]. However, from XRD software 
analysis, a peak showing an intensity of 1.0 % was observed at a 2-theta value of 6.305o 
and had a d-spacing value of 14.00704 Å. This is slightly larger than half the diameter of 
DNA. Perhaps the DNA binds to the outside of the HT/LDH and the DNA is further 
compacted/sandwiched between one or more particles. If this was the case; due to the 
electrostatic interaction, one would observe no FTIR bonding frequencies between the 
HT/LDH and the DNA, therefore the FTIR spectrum should exhibit a mixture of the 
HT/LDH and that of ‘free’ DNA.  
   
   
 
Figure 3.6 XRD pattern of (a) MgAl.31 and (b) DNA:MgAl.31. 
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From the FTIR spectrum (Figure 3.7), one observed that there appeared no bonding 
frequencies between the HT and DNA, in addition there appeared no evidence of ‘free’ 
DNA.  





























































From the XRD peak at a 2-theta value of 6.305 with an intensity of 1 %, in addition the 
concentration ratio of 1: 55 for XRD had to be scaled-up to 10 mg: 600 mg (DNA : 
MgAl.31), the absence of free DNA in the FTIR spectrum could be due to the low 
amount of DNA in relation to the overwhelming amount of MgAl.31. Hence FTIR 
bonding frequencies for DNA were not visible or simply the intensity of these bonding 
frequencies was too low to overcome the background threshold.  
TEM images of DNA:HT/LDH complexes (Figure 3.8) were captured for MgAl.26,  
ZnAl.11, ZnFe.24 and MgFe.58. The DNA:HT/LDH complex particles for Mg-Al HT 
samples showed a size range of 400-450 nm. Zn-Al LDH samples showed a size range of 
200 nm- >500 nm. Zn-Fe LDH samples showed a size range of 150-300 nm and Mg-Fe 





Figure 3.8 TEM images of DNA:HT/LDH complex complexes. (a) MgAl.26 (x250k), 
(b) ZnAl.11 (x250k), (c) ZnFe.24 (x200k), (d) MgFe.58 (x250k). 
 
(a) (b) 
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TEM images of DNA: MgAl.11 (Figure 3.9(a)-3.9(b)) show a distinct thin ‘lamella-like’ 
fissure between one/two HT particles lying side-on to the plane of view.  
 
 





Figure 3.9(b) TEM image of DNA:MgAl.31 (x500k) (Image captured at Carl Zeiss 
SMT, NTS). 
 
In relation to MgAl.31 without any DNA (Figure 3.10), TEM images indicates a visible 
decrease in the size of this fissure-thus complimenting the notion of DNA being 
sandwiched between two or more HT particles. Thus to support this notion, a nuclease 
digestion assay was conducted and should show increased degradation of DNA when the 
DNA:HT/LDH samples are subjected to nuclease enzymes-this is further discussed in 
section 3.2 to follow. The notion that DNA does not undergo full ion exchange with 
HT/LDH interlayer anions and simply binds to the external surface of one or more 
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Figure 3.12 Raman spectrum of MgAl.31. 
 
Raman spectroscopy (Figures 3.11-3.12) revealed a similar observation seen in both 
XRD and FTIR data showing no significant difference between that of MgAl.31 and 




















The ultimate fate of a carrier: DNA complex designed for gene delivery purposes, is the 
successful introduction of these complexes into a mammalian system and finally the 
subsequent release of bound DNA within the cell. All complexes whether introduced 
orally in a tablet / liquid form, applied to the skin or injected intravenously – must enter 
the blood stream where it encounters serum nucleases. Serum nuclease enzymes degrade 
nucleic acid molecules [119-121]. The second obstacle that these complexes need to 
overcome is the immune system and any undesired cytotoxic effects. This will be further 
discussed in cytotoxicity studies (Section 3.3). Finally, if the complex is able to enter into 
cells and subsequently release the bound DNA, does the DNA remain in an integral 
form? To address this question, a nuclease digestion assay is carried out in order to 
evaluate the affects of serum nuclease digestion as well as to determine if the DNA 
remains in an integral form once released into the cell. 
In this assay, DNA:carrier (HT/LDH) complexes are prepared as determined by the gel 
retardation assay i.e. the optimum DNA binding ratio as well as the ratio above and 
below optimum DNA binding are used. These complexes are then subjected to 10 % 
serum which contains nucleases- thus mimicking the environment that these complexes 
would come into contact with in the blood stream in vivo. After exposure to nuclease 
enzymes, a chelating agent is added to bind ions used by nuclease enzymes and thus 
inactivating the enzyme, ceasing nuclease digestion. Thereafter these complexes are 
subjected to a detergent which disrupts the interaction of the DNA and the carrier, 
releasing the DNA into solution. This solution is then subjected to agarose gel 
electrophoresis and hence the extent of nuclease digestion and the integrity of the DNA 
are visualized. When nucleases act on DNA, the DNA is broken down into smaller 
fragments, which will migrate differently depending on their size. They generally appear 
as a smear of bands on an agarose gel. Thus the appearance of smearing of DNA is 
evidence that the DNA bound to the carrier:DNA complex has been degraded by 
nucleases. This confirms that the carrier offers little protection against nuclease digestion. 
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The alternate situation would be that the carrier did afford some protection and hence the 
absence of smeared bands and the presence of distinct bands (three bands, depending if 
all forms of DNA were present) is evidence that no nuclease digestion occurred. Thus the 
released DNA remains in an integral form and is not degraded and migrates as would 
‘free’ DNA that has not been subjected to any form of digestion (i.e. standard control 
DNA). Thus for complexes that exhibit protection from nuclease digestion; one can 
assume that once introduced into the blood stream the bound DNA will remain integral 
from the time of administration up and until the complex reaches the nucleus of the cell 
where it is expressed.  
 
3.2.2 Materials and methods 
 
Reaction samples were prepared according to gel retardation complexes in the Table 3.1-
4, prior to nuclease digestion. Thereafter, to each sample and control two (DNA only), 10 
% v/v FCS (Gibco, Invitrogen, N.Z, U.K & N.Y.) was added and the samples were 
incubated at 37oC for 4 hours in a Memmert water bath. The nuclease digestion reaction 
was stopped by the addition of EDTA (Merck, Darmstadt, Germany) to the samples to a 
final volume of 10 mM. Thereafter 5 % (v/v) SDS ((Merck, Darmstadt, Germany) was 
added to each sample and the samples further incubated at 55oC for 20 minutes. 
Thereafter 2 μl gel loading buffer was added into each sample and the samples were 
loaded onto an eight well 1 % agarose gel and run at 50 V for 120 minutes. For each 
agarose gel, two controls were run alongside the samples. The first (control one) being 
standard DNA (0.5 μg) in a buffered solution and control two, ‘free’ DNA (0.5 μg) 
subjected to nuclease digestion. After electrophoresis the gel was then removed and 








3.2.3 Results and discussion 
 
From gel retardation assays for Mg-Al HT samples, complete retardation was observed 
for DNA:MgAl.31 and  DNA:MgAl.34 complexes. Nuclease digestion assays performed 
on these complexes (Figures 3.13, 3.14 lanes 3, 4, 5 respectively) showed two distinct 
bands for both samples with DNA: MgAl.34 complexes showing lighter bands after 
addition of the detergent. Some DNA degradation was observed (smearing of bands 
similar to control lane two) in several of the gels. In addition, for all gels the majority of 
the DNA that was bound to the HT/LDH samples appeared to remain in the wells and 
was not sufficiently released upon addition of the detergent. The degradation for DNA 
bound to MgAl.31 and MgAl.34 samples, could provide further evidence that the DNA 
did not completely intercalate via ion exchange and hence, either bound to the peripheral 
of the HT exterior or in fact incomplete ion exchange occurred in which the DNA was 
partially intercalated leaving protruding DNA. From XRD and FTIR data the former was 
assumed. Thus if DNA bound to the exterior of the HT samples, little protection would 
have been provided to the DNA and nuclease digestion would occur. The subsequent 
release of DNA from the DNA:HT/LDH complexes after nuclease inactivation was 
carried out using an anionic detergent SDS. Although this detergent released DNA from 
the DNA:HT/LDH complexes, it was not totally efficient with some samples showing 
some DNA remaining in the well bound to HT/LDH samples. This could perhaps be due 
to the fact that SDS, due to its anionic nature as well as small size in relation to DNA, 
favoured intercalation (via ion exchange) into the DNA:HT/LDH complex thus resulting 
in partial release of DNA. Other methods of DNA release were attempted in place of 
SDS. These included the use of HCl and HNO3 of varying concentration ranges (100 
mM-1M), however these proved to give inconsistent results, in most cases inefficient 
release of DNA. Another method using a carbonate solution Na2CO3 [65] was carried out, 
however in all cases no DNA was released. Although not completely releasing all bound 
DNA, SDS appeared to be most reliable and consistent. HTs have been used as an antacid 
in medicine for a number of years and this is due to the fact that HT is capable of 
buffering the pH of the stomach at about pH 4 for extended periods of time [74]. This 
could explain the inefficient slow release of DNA using acid such as HCl/HNO3. This 
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buffering mechanism appeared to be evident during release of DNA into cells as 
described in the transfection of mammalian cells in section 3.4. In addition, the slow 
controlled release of biomolecules and pharmaceutics from Mg-Al HTs and LDHs has 
been reported in literature [25-28, 67, 73, 122]. 
 
 
Figure 3.13 Nuclease digestion assay of MgAl.26 HT and MgFe.55 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:35 MgAl.26 
Lane 4 = 1:40 MgAl.26 
Lane 5 = 1:45 MgAl.26 
Lane 6 = 1:25 MgFe.55 
Lane 7 = 1:30 MgFe.55 
Lane 8 = 1:35 MgFe.55 
DNA was kept constant at 0.5 μg. 
 
 1       2       3       4       5       6        7      8 
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Figure 3.14 Nuclease digestion assay of MgAl.31 HT and MgFe.58 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:50 MgAl.31 
Lane 4 = 1:55 MgAl.31 
Lane 5 = 1:60 MgAl.31 
Lane 6 = 1:45 MgFe.58 
Lane 7 = 1:50 MgFe.58 
Lane 8 = 1:55 MgFe.58 
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Figure 3.15 Nuclease digestion assay of MgAl.34 HT and MgFe.62 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:35 MgAl.34 
Lane 4 = 1:40 MgAl.34 
Lane 5 = 1:45 MgAl.34 
Lane 6 = 1:30 MgFe.62 
Lane 7 = 1:35 MgFe.62 
Lane 8 = 1:40 MgFe.62 
DNA was kept constant at 0.5 μg. 
 
DNA degradation was also observed for MgAl.26 (Figure 3.13, lanes 3, 4, 5), however, 
this could be attributed to the fact that partial gel retardation was observed with unbound 
 1       2        3       4       5        6       7       8 
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DNA undergoing nuclease digestion. However, the notion of the DNA binding on the 
periphery of the HT samples, as described should also be taken into consideration. 
All Zn-Al and Zn-Fe LDH samples showed partial retardation of DNA, with much of the 
DNA remaining unbound. As seen from nuclease digestion assays (Figures 3.16-18), this 
DNA was degraded as evident from the smearing of DNA down the gels. No distinct 
bands of released DNA was observed for most samples, with the exception of 1:30 
ZnFe.30, 1:35 and 1:40 ZnFe.32 samples which showed released DNA.  
 
Figure 3.16 Nuclease digestion assay of ZnAl.11 LDH and ZnFe.24 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:60 ZnAl.11 
Lane 4 = 1:65 ZnAl.11 
Lane 5 = 1:70 ZnAl.11 
Lane 6 = 1:30 ZnFe.24 
Lane 7 = 1:35 ZnFe.24 
Lane 8 = 1:40 ZnFe.24 
DNA was kept constant at 0.5 μg. 




Figure 3.17 Nuclease digestion assay of ZnAl.14 LDH and ZnFe.30 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:40 ZnAl.14 
Lane 4 = 1:45 ZnAl.14 
Lane 5 = 1:50 ZnAl.14 
Lane 6 = 1:30 ZnFe.30 
Lane 7 = 1:35 ZnFe.30 
Lane 8 = 1:40 ZnFe.30 








Figure 3.18 Nuclease digestion assay of ZnAl.16 LDH and ZnFe.32 LDH. 
Lane 1 = pCMV-GFP (0.5 μg) 
Lane 2 = pCMV-GFP (0.5 μg) + 10% FCS 
Lane 3 = 1:40 ZnAl.16 
Lane 4 = 1:45 ZnAl.16 
Lane 5 = 1:50 ZnAl.16 
Lane 6 = 1:30 ZnFe.32 
Lane 7 = 1:35 ZnFe.32 
Lane 8 = 1:40 ZnFe.32 
DNA was kept constant at 0.5 μg. 
Both MgFe.55 and MgFe.58 showed full retardation of DNA at 1:30 and 1:50 
respectively. From nuclease digestion results (Figure 3.13, 3.14 lanes 6, 7, 8), DNA 
degradation was observed. However most of the DNA was not released as evident from 
1       2        3       4        5       6        7       8 
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the DNA remaining within the well. MgFe.62 (Figure 3.15 lanes 6, 7, 8) showed DNA 
degradation; however this sample showed partial retardation with much unbound DNA 
remaining in solution. 
Nuclease digestion gels showing bands of released DNA from respective samples 
(MgAl.26, MgAl.31, MgAl.34, ZnFe.32), showed that the migration of these bands did 
not appear to match that of the bands of free DNA (marker lane one)- this could be 
attributed to the fact that upon binding to the HT/LDH the released DNA underwent a 
conformational change appearing in one or more forms of DNA thus migrating 
differently, alternatively the addition of serum could have affected the released DNA’s 
migration.  Thus from nuclease digestion assays, although majority of the DNA was not 
released and remained bound to the HT/LDH, DNA degradation was evident. The 
degradation of DNA upon encountering serum can thus decrease the amount of delivered 
DNA into mammalian cells thus decreasing the delivery efficiency. Therefore these 
nuclease digestion results can be further supported in conjunction with transfection 
results.  
According to Costantino et al. [123], the selectivity of anions within the interlayer of 
LDHs is as follows, CO23- > SO42- >> OH- > F- > Cl- > Br- > NO3- > ClO4-. Thus LDHs 
containing nitrate anions are the most suitable precursors for the uptake of biologically 
active species [123]. Thus the high electrostatic affinity of CO23- potentially hinders the 
ion exchange of DNA into the HT/LDH interlayer region. This further supports the 
evidence obtained from XRD, FTIR as well as nuclease digestion assays that the DNA 









Prior to performing gene delivery experiments (transfection), the cytotoxicity of the HTs 
and LDHs to mammalian cells was investigated in order to determine a safe 
concentration range to be used. 
In this study, human embryonic kidney (HEK293), hepatocellular carcinoma (HepG2) 
and cervical epithelial carcinoma (HeLa) mammalian cell lines where utilized in 
evaluating cytotoxicity. The cell viability in the presence of the various LDH materials 
can be determined by making use of a cell proliferation assay such as the MTS (3-(4,5-
dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salts) assay. The MTS assay is a relatively simple and quick colorimetric method 
used to measure dehydrogenase activity in metabolically active cells. Specifically, 3-(4,5-
dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salts (MTS) with the electron coupling reagent, phenazine methosulphate (PMS) 
[124], is reduced to formazan in the presence of metabolically active cells. Specifically, 
the reduction reaction by the enzyme dehydrogenase takes place in the mitochondria of 
metabolically active cells. The absorbance of the reduced formazan (soluble) is 
proportional to the number of viable cells in culture and hence one is able to determine 
the cell viability in relation to untreated control cells. 
In the present study, divalent cations (MII), Mg2+ and Zn2+ as well as trivalent cations 
(MIII), Al3+ and Fe3+ were selected in the preparation of hydrotalcite and LDH 
compounds. The choice of MII and MIII was based upon the natural occurrence of these  
ions in the human body. Thus as these compounds were designed for studies on 
mammalian cells, the composition of these compounds was of significant importance so 
as to minimize toxic effects, if any; that these HT and LDH compounds could perhaps 
have in mammalian systems.  
Magnesium (Mg) is the second most abundant intracellular cation in the human body. On 
average, a human adult exhibits a body content of 20-28 g of magnesium. The adult 
recommended daily allowance (RDA) for magnesium is 400-420 mg for men and 310 -
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320 mg for women. According to Mahan and Escott-Stump [125], magnesium excesses 
from diet or supplementary sources are unlikely to result in toxicity; however a tolerable 
upper intake level is indicated at 350 mg/day for males and females. 
Iron (Fe) is found throughout each cell in the body, with a total body content of about 5 g. 
The adult RDA for iron is 10 mg/day for men and 15 mg/day for women, although on 
average, men consume about 17 mg and women, 12 mg iron per day [126]. Toxicity of 
iron due to over dosage results when serum iron levels are greater than 180 mg/dl [125]. 
Wardlaw [126] states iron toxicity occurs when iron intakes exceed that of the RDA for 
prolonged period of times. 
Zinc (Zn) is the second most abundant trace element after iron. Zinc is found to have a 
total body content or 2-3 g in an adult human. The RDA of zinc is 15 mg/day for men and 
12 mg/day for women. On average, men consume about 15 mg and women, 9 mg zinc 
per day [126]. Mahan and Escott-Stump [125] indicate that the RDA for adult males is 11 
mg/day and for women 8 mg /day. Zinc toxicity occurs in which zinc intake exceeds 2 g / 
day. However, both Wardlaw and Mahan and Escott-Stump indicate that zinc intakes 
over 100 mg/day results in gastrointestinal tract irritation, nausea and depression of the 
immune system [125, 126]. 
Aluminium (Al) is considered a non-essential trace element with no known biological 
requirement [127]. On average, adults will consume 2-5 mg/day from food and water 
sources. It has been shown clinically and experimentally that Al is toxic to bone, the 
central nervous system and the liver [127]. From clinical data involving patients being 
subjected to subcutaneous injections of alum-precipitated allergenic extracts for 2-4 
weeks, the maximum allowance of Al was 0.85 mg/5000 protein-N units per day. 
The nutritional data on the toxicity of trace elements such as, Mg, Zn, Fe and Al indicates 
that the amounts used in biochemical studies may not be toxic. Such amounts are in the 
micro-gram quantities, thus it is anticipated that DNA: HT/LDH compounds would 






HEK293 cell line 
HEK293 (Figure 3.19) is a human embryonic kidney derived cell line which has been 
widely used in cellular biology experiments due to their relative ease in propagation and 
transfection abilities in culture. The HEK293 cell line was originally generated in the 
1970’s by Frank Graham, in which normal cultures of human embryonic kidney cells 
were transfected with sheared adenovirus 5 DNA. It was determined that this 
transformation resulted in the insertion of a 4-5 kilobase fragment from the left arm of the 
viral genome into HEK DNA. The resultant cell line, Graham numbered as his 293rd 
experiment. i.e. HEK293 [105]. HEK 293 cells exhibit the following native receptor 
proteins; corticotrophin releasing factor type 1 receptor, sphingosine-1-phosphate 
receptors EDG1, EDG3, EDG5, muscarinic acetylcholine receptor M3 and transient 
receptors TRPC1,2,4,6 [105].  
 
 
Figure 3.19 Image of HEK293 cells (x100) captured using an Olympus fluorescence 
microscope. 
 
HepG2 cell line 
HepG2 (Figure 3.20) is a human liver cell line isolated by Knowles et al. [128] from a 
teenage Caucasian male from Argentina with primary hepatoblastoma & hepatocellular 
carcinoma. It was initially derived from minces of hepatoma biopsy tissue placed on 
feeder layers of the mouse cell line STO [129], irradiated to the point of non-division. 
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Hepatoma sub-lines were selected after several months by feeder-independent in vitro 
growth in minimum essential medium (MEM) supplemented with fetal calf serum. After 
serial passage in MEM more than 50 times, HepG2 cells were reported to have 
continuing chromosome abnormalities (i.e. between 50 & 56 chromosomes) with 
characteristic rearrangement of chromosome one, in addition they were shown to retain 
the morphology and many of the biosynthetic capabilities of normal liver cells [130]. 
Thus as HepG2 expresses many morphological and biosynthetic capabilities of normal 
liver cells, for example; triglyceride and cholesterol metabolism; the HepG2 cell line is 
thus an ideal cell line in order for one to study fundamental functions of the liver. In 
addition to liver-specific metabolic functions, HepG2 also expresses many receptors; of 
which the asialoorosomucoid (AOM) receptor is found exclusively in the liver cells, thus 
making the HepG2 cell line important when undergoing studies relating to targeting of 
specific receptors on specific cells in gene therapy strategies.  
HepG2 cells are also used in the study of the regulation of hepatic protein synthesis by 
cytokines (e.g. acute phase proteins) [131], as well as cancer and apoptosis studies [132]. 
In addition HepG2 cells are found to contain numerous amounts of mitochondria, which 
makes the HepG2 cell line ideal in the study of mitochondrial toxicity experiments. 
HepG2 cells, when grown in culture flasks, adhere to the surface of the culture flask, 
forming a monolayer of cells; thus the HepG2 cells are not damaged/ lost when medium 
is removed/ renewed from the culture flask. A disadvantage of HepG2 cells is their 
unpredictability relating to their metabolism in adult human liver cells, as expression of 
drug-metabolizing enzymes are different to in vivo conditions [133]. 
 
Figure 3.20 Image of HepG2 cells (x100) captured using an Olympus fluorescence 
microscope. 
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HeLa cell line 
HeLa (Figures 3.21, 3.22) is human epithelial cell line which was derived from cervical 
cancer cells taken from a Ms Henrietta Lacks, who died from her cancer in 1951. HeLa 
cells originated from a fatal cervical carcinoma transformed by the human papillomavirus 
18 (HPV18). As the HeLa cells were originally taken from a biopsy from Ms Lack’s 
cervix in her diagnosis of her cervical carcinoma; these cells are treated as cancer cells. 
HeLa cells proliferate abnormally quickly, even compared to other cancer cells. In 
addition, HeLa cells have an active version of the enzyme telomerase during cell 
division, which prevents the shortening of telomeres that is implicated in aging and 
eventual cell death. Thus due to the HeLa cells containing telomerase; aging and cell 
death is unlikely to occur; which results in the HeLa cells evading the Hayflick Limit, 
which is the threshold number of cell divisions that normal cells undergo before dying 
out in a cell culture. 
The HeLa genome was formed by the horizontal gene transfer from human 
papillomavirus 18 (HPV18) to human cervical cells. Notably, HeLa cells have a 
chromosome number of 82, with four copies of chromosome 12 and three copies of 
chromosome 6, 8, and 17, which is different from both the contributing parent genomes. 
HeLa cells; like HepG2 cells, when grown in culture flasks, adhere to the culture flask 
forming a monolayer of cells. In addition HeLa cells maintain contact inhibition in vitro; 
in that, as the cells multiply across the surface of the culture flask, when two adjacent 
cells come into contact with one another, the cells will signal to stop growing. A loss of 
contact inhibition is a typical sign of tumour cells (oncogenic cells). Such cells not only 
form a monolayer in culture but also stack up on top of one another forming clumps of 
cells (tumours). Generally HeLa cells are not oncogenic in animals, however; they may 




                  Figure 3.21 Phase contrast image of HeLa cells in culture (x100) [134]. 
 
         













3.3.2 Materials and methods 
 
3.3.2.1 Preparation of culture medium 
 
One packet of minimum essential medium (MEM) + glutamine (Gibco, Invitrogen, N.Z, 
U.K & N.Y) was emptied into a sterile 2 litre glass beaker. Thereafter 900 ml of 18 
Mohm water was added and mixed thoroughly using a magnetic stirrer, upon which, 10 
mM NaHCO3 (Merck, Darmstadt, Germany) was added. This was followed by the 
addition of 20 mM HEPES (Merck, Darmstadt, Germany) and 10 ml Penicillin/ 
streptomycin antibiotic mixture (Gibco, Invitrogen, N.Z, U.K & N.Y. 10 000 units 
penicillin/streptomycin / ml mixture). This solution was then made up to the 1 litre mark 
with 18 Mohm water and the pH was corrected to the optimum range of 7.3-7.4. The 
medium was then filtered through a 0.22 μm Sterivex milipore bell filter using a 
Masterflex® automatic peristaltic dispenser pump, into 5 equal 200 ml aliquots in sterile 
250 ml wide-neck blue cap Schott bottles. Thereafter the medium was labeled and stored 
in the refrigerator at 4oC. Prior to use, the medium was replenished with 10% Fetal calf 
serum (FCS) (Gibco, Invitrogen, N.Z, U.K & N.Y). 
 
3.3.2.2 Preparation of buffers 
 
Phosphate buffered saline (PBS) (pH = 7.3-7.4) 
Approximately 140 mM NaCl, 4 mM KCl, 0.88 mM KH2PO4 (anhydrous) and 7.5 mM 
NaH2PO4 (anhydrous) (Merck, Darmstadt, Germany) were made up in 18 Mohm water to 
a total volume of one litre. The pH was adjusted and the solution autoclaved and stored in 
the refrigerator at 4oC. 
 
HEPES buffered saline (pH = 7.3-7.4) 
Approximately 20 mM HEPES and 150 mM NaCl (Merck, Darmstadt, Germany) were 
made up in 18 Mohm water to a total volume of one litre. The pH was adjusted and the 
solution autoclaved and stored in the refrigerator at 4oC. 
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3.3.2.3 Reconstitution of cells 
 
Cells contained in cryovials which were previously frozen in a NuAire -86 oC Ultralow 
biofreezer were removed from the biofreezer using protective gloves and subsequently 
allowed to thaw in their vials in a water bath; set at 37 oC. Fetal calf serum and medium 
were removed from the refrigerator and placed in the 37 oC water bath. Once the cells 
were thawed and the FCS and medium had reached 37 oC; the vial containing the cells 
and the bottles containing the medium and FCS were wiped with 70% ethanol. The cells 
were then pelleted at 1000 rpm for 5 minutes and the tube containing the pelleted cells 
was opened aseptically in a class III biohazard safety cabinet. The medium (supernatant) 
was decanted and was reconstituted in 1 ml fresh medium, which contained 10% FCS. 
The cells were then transferred to a 25 cm2 flask containing 5 ml complete medium 
(MEM, 10% FCS). The flask was then placed in a Zenith incubator set at 37 oC, and 
allowed to incubate overnight. The cells were allowed to attach to the flask before the 
medium was replenished and any cryoprotective medium or dead cells would be 
removed. HEK293 cells were obtained from The University of Witwatersrand, RSA. 
HepG2 cells and HeLa cells were obtained from Highveld Biologicals, Gauteng, RSA. 
 
3.3.2.4 Trypsinization of cells 
 
Subculturing was done when the cells were near or at confluency. The culture flask was 
removed from the incubator and the medium was decanted into a sterile waste bottle and 
the bottles neck was flamed in a class II biohazard safety cabinet. The cells in the culture 
flask were then washed with 5 ml PBS. Approximately 1 ml of Trypsin / Versene (Gibco, 
Invitrogen, N.Z, U.K & N.Y.) was added to cover the cells. Trypsinization was allowed 
to occur at room temperature for 1-5 minutes (depending on enzyme activity and type of 
cell line used). The culture flask was then placed on the stage of a Nikon TMS inverted 
microscope and the rounding off of the cells was observed (magnification, 10x). After 
this rounding off of cells, the culture flask was tapped against the palm of ones hand 
causing the trypsinized cells to dislodge off the flask surface. The cells were reconstituted 
with 2 ml of MEM containing FCS at least 10 times the volume of Trypsin / Versene in 
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order to inhibit the enzyme. The cells were then split (1:2) into separate 2 x 25 cm2 flasks 
each containing, 5 ml MEM and 10% FCS. The cell suspension was drawn up and 
expelled repeatedly, using a sterile 1 ml pipette, to evenly distribute the cells before they 
were divided into the 25 cm2 flasks. Cells were then incubated at 37 oC. Cells were 
subcultured every 2 - 3 days or when the cells were near or at confluency. 
 
3.3.2.5 Cell count 
 
Cells were successfully propagated in MEM +10 % FCS and trypsinized. After 
trypsinization, cells were observed on a Nikon TMS inverted microscope (magnification, 
10x) and approximately 0.1 ml of the trypsinized cells were placed on a hemacytometer.  
 
 
3.3.2.6 MTS cell proliferation assay 
Cells were trypsinized and seeded into a 48 well plate at a seeding density of 3.5-4 x 105 
cells / well and were incubated overnight in a Zenith incubator set at 37oC, allowing cells 
to attach to the wells and grow to semi-confluency. The medium was then removed and 
replaced with 0.2 ml of serum free medium. Thereafter the respective compounds were 
added as depicted in Table 3.6. The same LDH concentration was utilized for all other 
LDH samples and a similar culture plate layout was employed for each compound 












Table 3.6 Culture plate arrangement indicating concentration (μg/10 μl) of each Mg-Al 
HT sample added into each well. 








































































































The cells were then incubated at 37 oC for 4 hours, after which, the medium was then 
removed and replaced with 0.2 ml complete medium into each well. This was followed 
by further incubation of the cells at 37 oC for 48 hours. Approximately 10 minutes before 
the completion of the 48 hour incubation time, CellTiter 96® Aqueous One Solution 
Reagent (Promega Cooperation, Madison, USA) was thawed out for 10 minutes in a     
37 oC water bath. Thereafter 40 μl of One Solution Reagent was added into each well 
containing 0.2 ml medium. The plate was further incubated for 4 hours at 37 oC. On 
completion of this incubation period, the contents of each well were read at 490 nm using 
a Biomate 3 scientific spectrophotometer and absorbance values noted. 
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3.3.3 Results and discussion 
 
Mg-Al HT samples showed little toxicity in all cell lines with cell viability in the range of 
80-100 % for most Mg-Al samples. With exceptions of MgAl.26 (20 μg / 10 μl) exposed 
to HepG2 cells and MgAl.34 (20 μg / 10 μl) exposed to HeLa cells (Figures 3.24 and 
3.25 respectively) which showed a cell viability slightly lower than 80 %. There does not 
appear to be any trend with respect to the three different Mg-Al HT samples over the 
concentration range in all the cell lines. There does however appear to be a similar trend 
in toxicity in comparison to Zn-Al LDH samples. All comparisons of trends in toxicities 
discussed are based upon the overall trends over the entire concentration range from 0-
100 μg / 10 μl and not individually for each sample. When comparisons of individual 
samples are made, these comparisons are based upon samples containing the most or least 
amount of trivalent cation. i.e. MgAl.26 and ZnAl.11 may be compared, based upon the 
fact that both samples contain the highest amount of divalent cation with respect to the 
other samples of the same composition. Just as MgAl.34 and ZnAl.16 may be compared 
since both samples contain the least amount of trivalent cation. 
Figures 3.23 and 3.26 over the exposed concentration range show a very similar trend 
with an average cell viability of 90-100 % and 80 % respectively. Figures 3.24 and 3.27 
show a similar trend across the exposed concentration range with an average cell viability 
of 90-100 % and 80-85 % respectively. In both cases the cell viability for 20 μg / 10 μl of 
MgAl.26 (Figure 3.24) and ZnAl.11 (Figure 3.27) show a cell viability of 54 % which 
subsequently increases. ZnAl.16 (Figure 3.27) shows a slightly different trend to that of 
MgAl.34 (Figure 3.24). Overall, the cell viability of Mg-Al HTs and Zn-Al LDHs is very 
similar in the HepG2 cell line. Figures 3.25 and 3.28 show similar trends across the 
exposed concentration range with the exception of MgAl.31, MgAl.34 and ZnAl.14, 
ZnAl.16 at concentrations of 20 μg / 10 μl (Figures 3.25 and 3.28 respectively).  
As Al is constant throughout all Mg-Al HT and Zn-Al LDH samples with slight changes 
in Mg or Zn content it is thus not unexpected that there are similar trends in toxicities. In 
all cell lines in the exposed concentration ranges it appears that the divalent cation is 
responsible for decreases in cell viabilities. However the combination of Zn and Al, in 
relation to Mg-Al HTs, appears to decrease the cell viability to 80 % as apposed to an 
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average of mostly 100% for Mg-Al HT samples. Both Mg-Al and Zn-Al samples appear 
to be well tolerated by all three cell lines (with exception of 20 μg / 10 μl of MgAl.26 
(Figure 3.24) and ZnAl.11 (Figure 3.27) in the HepG2 cell line). The low toxicity of Mg-
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Figure 3.23 MTS cell proliferation assay of HEK293 cells exposed to Mg-Al HTs. HT 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg HT) 
containing only HEK293 cells was assumed to have 100 % survival. Data are presented 


















0 20 40 60 80 100


















Figure 3.24 MTS cell proliferation assay of HepG2 cells exposed to Mg-Al HTs. HT 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg HT) 
containing only HepG2 cells was assumed to have 100 % survival Data are presented as 
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Figure 3.25 MTS cell proliferation assay of HeLa cells exposed to Mg-Al HTs. HT 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg HT) 
containing only HeLa cells was assumed to have 100 % survival. Data are presented as 
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Figure 3.26 MTS cell proliferation assay of HEK293 cells exposed to Zn-Al LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HEK293 cells was assumed to have 100 % survival. Data are presented 
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Figure 3.27 MTS cell proliferation assay of HepG2 cells exposed to Zn-Al LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HepG2 cells was assumed to have 100 % survival. Data are presented as 
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Figure 3.28 MTS cell proliferation assay of HeLa cells exposed to Zn-Al LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HeLa cells was assumed to have 100 % survival. Data are presented as 














Zn-Fe LDHs showed an average cell viability of 80 % with the exception of ZnFe.24 (20-
40 μg / 10 μl) and ZnFe.30 (30 μg / 10 μl) in the HepG2 cell line (Figure 3.30) which 
showed a cell viability of 68-70 % and 72 % respectively. Likewise with Mg-Al HT 
samples, there does not appear to be any trend with respect to the three different Zn-Fe 
LDH samples over the concentration range in all the cell lines. There does however 
appear to be a similar trend in toxicity in comparison to Mg-Fe LDH samples. Figures 
3.29 and 3.32 show a similar trend of cell viability with an average cell viability of above 
100 % for both Zn-Fe and Mg-Fe LDHs. However, Zn-Fe LDH cell viability decreases at 
100 μg / 10 μl (Figure 3.29). In addition, 20 μg / 10 μl of MgFe.58 in the HEK293 cell 
line (Figure 3.32) shows an increased cell viability to that of 20 μg / 10 μl ZnFe.30 
(Figure 3.29).  
Both Zn-Fe and Mg-Fe LDH samples show a decrease in cell viability with an average 
cell viability of 80 % (Zn-Fe LDHs) and 80-85 % (Mg-Fe) in the HepG2 cell line 
(Figures 3.30 and 3.33 respectively). This is in stark contrast to both Zn-Fe (Figures 3.29 
and 3.31) and Mg-Fe (Figures 3.32 and 3.39) LDH samples in the HEK293 and HeLa cell 
lines with an average cell viability in excess of 100 %. Zn-Fe LDH samples at 20 μg / 10 
μl show a decrease in cell viability to a value of about 65-80 % (Figure 3.30). This lower 
cell viability for 20 μg / 10 μl is seen in Mg-Al HT and Zn-Al LDH samples in the 
HepG2 cell line. Mg-Fe LDHs show a higher cell viability in the HepG2 cell line. This is 
similar to the Zn-Fe LDHs in the same cell line. 
Both Zn-Fe and Mg-Fe LDHs exhibit similar toxicity levels with an average cell viability 
in excess of 100 %. At 20 μg / 10 μl of MgFe.62 (Figure 3.34) shows a higher cell 
viability to that of ZnFe.32 (Figure 3.31) in the HeLa cell line. Overall, both Zn-Fe and 
Mg-Fe LDHs appear to be well tolerated within all three cell lines. 
Based upon the similarities in toxicities of Zn-Fe and Mg-Fe LDHs, it appears that the 
LDH samples are least tolerated by the HepG2 cell line, yet cell viability remains on 
average above 80 %. Furthermore, out of all the samples synthesized, it appears that the 
presence of Fe in these LDH samples promotes cell growth with the highest cell viability 
values seen in the HEK293 and HeLa cell lines. The increase in cell proliferation could 
be due to the increased amounts of intracellular Fe which in turn increases the redox 
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potential and thus increases oxidative processes within the cells and hence the increase in 
cell viability. 
Concentrations of HT and LDH samples used in gene delivery studies (transfection) are 
in the ranges of 35 - 40 μg / 10 μl (Mg-Al HTs), 40 - 70 μg / 10 μl (Zn-Al LDHs), 30 – 
40 μg / 10 μl (Zn-Fe LDHs) and 25 – 55 μg / 10 μl (Mg-Fe LDHs). Cell viability in these 
ranges for each respective sample in all cell lines is on average in excess of 80%, with the 
exception of ZnFe.24, ZnFe.30 (20 - 40 μg / 10 μl) and MgFe.55 (40 μg / 10 μl) in the 
HepG2 cell line which showed cell viabilities of below 80 %. Thus the HT and LDH 
samples appear to be well tolerated within all cell lines. There appears to be no published 
data on the toxicity of Zn-Al, Zn-Fe or Mg-Fe LDHs in literature. Due to the similar 
structure, chemistry and binding studies that LDHs exhibit to that of HTs, it is thus not 
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Figure 3.29 MTS cell proliferation assay of HEK293 cells exposed to Zn-Fe LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HEK293 cells was assumed to have 100 % survival. Data are presented 
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Figure 3.30 MTS cell proliferation assay of HepG2 cells exposed to Zn-Fe LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HepG2 cells was assumed to have 100 % survival. Data are presented as 
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Figure 3.31 MTS cell proliferation assay of HeLa cells exposed to Zn-Fe LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HeLa cells was assumed to have 100 % survival. Data are presented as 
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Figure 3.32 MTS cell proliferation assay of HEK293 cells exposed to Mg-Fe LDHs. 
LDH concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HEK293 cells was assumed to have 100 % survival. Data are presented 
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Figure 3.33 MTS cell proliferation assay of HepG2 cells exposed to Mg-Fe LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HepG2 cells was assumed to have 100 % survival. Data are presented as 
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Figure 3.34 MTS cell proliferation assay of HeLa cells exposed to Mg-Fe LDHs. LDH 
concentration was varied (0, 20, 40, 60, 80, 100 μg). A control sample (0 μg LDH) 
containing only HeLa cells was assumed to have 100 % survival. Data are presented as 
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In order to determine whether HT and LDH compounds have the ability to efficiently 
deliver DNA into mammalian cells and bring about sustained gene expression; a 
transfection study is conducted. Many non viral vectors have been utilized as gene 
delivery vehicles, but only recently have HTs and LDHs thought to have the potential as 
gene delivery vehicles [13, 25-28, 115, 135]. In this study, the qualitative analysis of 
transfection was carried out using the green fluorescent protein (GFP) assay and 
quantitative analysis was carried out using the luciferase reporter gene assay. GFP 
analysis was carried out in the HeLa cell line and the luciferase assay was done using all 
three cell lines. GFP has been utilized as a marker or reporter gene in transfection studies 
for the simple reason that once the gene encoding GFP is expressed in a cell, the GFP 
protein will fluoresce when irradiated with ultra violet light (UV) at a wavelength of 395 
nm. Thus plasmids containing the GFP gene provide a visual analysis of gene expression 
within mammalian cells.  
The GFP was first discovered and isolated by Osamu Shimomura in 1960, during his 
studies on the bioluminescence of the crystal jellyfish, Aequorea victoria. Shimomura 
determined that in order for Aequorea Victoria’s bioluminesce, calcium ions are released. 
These released calcium ions then bind to a specific protein aequorin, which releases blue 
light upon this calcium binding. Subsequently this blue light is absorbed by GFP which in 
turn presents with green light emission. The structure of GFP consists of 238 amino acids 
(crystal structure elucidated in 1996), which are further arranged into 11 β-strands that 
make up the β-barrel and an α-helix which runs through the centre of the β-barrel. The 
chromophore responsible for GFPs fluorescence is located in the centre of the β-barrel. 
The GFP structure; where R1 and R2 = first 64 and last 170 residues of GFP respectively, 
can be seen in Figure 3.35 below. 
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In this study, the qualitative analysis of transient gene expression was carried out using 
plasmid pCMV-GFP encoding the GFP (Figure 3.36). This plasmid has a size of 3487 
base pairs. It contains a strong promoter; the cytomegalovirus (CMV) promoter, an 
antibiotic resistance gene (Kanamycin), a bacterial origin of replication, the simian virus 
40 polyadenylation gene (SV40 pA) and the GFP gene. The GFP transfection assay was 
not only used to capture a visual analysis of transfection, but in addition to determine the 
optimum incubation time in which transfection was at its optimum. Hence the luciferase 
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In addition to the GFP assay, qualitative analysis of gene expression was carried using 
the luciferase reporter gene assay in all cell lines respectively.  
The luciferase gene was first isolated from the North American firefly Photinus pyralis. 
This enzyme has been extensively studied in the catalysis of light production in 
bioluminescent organisms.  
The luciferase reactions involved in the Luciferase assay are as follows; 
 
              Mg2+ 
luciferase + luciferin + ATP       luciferase-luciferyl-AMP + PPi  
luciferase-luciferyl-AMP + O2  luciferase + oxyluciferin + AMP + CO2 + hv 
 
The initial reaction results in the formation of an enzyme-bound luciferyl-adenylate. The 
second reaction involves the oxidative decarboxylation of this luciferyl-adenylate to 
produce oxyluciferin, AMP, CO2 and light (hv). Thus, as luciferase comes into contact 
with excess substrate, the reaction as depicted above; produces a flash of light measured 
as Relative light units (RLU) that is directly proportional to the quantity of luciferase in 
the reaction mixture. In this study, the plasmid pCMV-luc encoding the luciferase gene 
was utilized (Figure 3.37). This plasmid has a size of 6233 base pairs. It contains a strong 
promoter; the simian virus (SV40) promoter, SV40 enhancer, SV40 late polyadenylation 
site, an antibiotic resistance gene (Ampicillin), bacterial origin of replication and the 
luciferase gene (luc). Thus upon the entry of the plasmid into eukaryotic cells, the 
luciferase gene is expressed, and upon the addition of substrates, luciferin, ATP and 
oxygen; results in light production that is measured in a luminometer. The luciferase gene 
is composed of seven exons separated by six extremely short introns ranging from 48-58 
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Figure 3.38  Structure of the P.pyralis luciferase gene. Introns are depicted as shaded 
boxes, with Exons depicted by non-shaded boxes. In addition; indicated are intron 
sequences 1-5. Furthermore, Restriction sites abbreviations as follows; Ps = Pst 1, Sp = 
Ssp 1, Xb = Xba 1, R1=EcoR 1, Bs=Bsm 1, and RV=EcoR V. 
 
Upon completion of the determination of luciferase activity (RLU), the amount of protein 
in the respective cell lysates used were determined using the Bicinchoninic Acid (BCA) 
Assay. The principle of the BCA Assay is alike the Lowry procedure, in that both rely on 
the development of a Cu2+ - protein complex under alkaline conditions, followed by the 
reduction of Cu2+ to Cu1+. The amount of reduction is proportional to the protein present. 
It has been observed that cystine, cysteine, tyrosine, tryptophan and peptide bonds are 
able to reduce Cu2+ to Cu1+. BCA forms a purple-blue complex with Cu1+ in alkaline 
environments, thus providing the basis to monitor the reduction of alkaline Cu2+ by 
proteins at an absorbance maximum of 562 nm. The BCA is much more applicable and 
sensitive than the Lowry or Biuret methods and less variable than the Bradford assay. 
The BCA assay has advantages such as lower susceptibility to detergents, the formed 
colour complex is stable, and is applicable over a wide range of protein concentrations. 
0           1.0      2.0              3.0  4.0 
Kilobases 
1388 
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Sample protein concentrations are hence determined with the use of a standard protein 
curve.  
In this study, the qualitative analysis of transfection was carried out using the green 
fluorescent protein (GFP) assay and quantitative analysis was carried out using the 
luciferase reporter gene assay.  
 
 
3.4.2 Green fluorescent protein transfection assay 
 
3.4.2.1 Materials and methods 
 
HeLa cells were first trypsinized (as per section 3.3.2.4) and seeded into a 48 well plate at 
a cell density of 3.5-4 x 105 cells / well and incubated at 37oC overnight. Reaction 
complexes were prepared (Tables 3.1-3.4) prior to GFP assay. Thereafter the growth 
medium was removed and replaced with 0.5 ml of complete medium into each well. 
Thereafter the optimum binding ratio (Table 3.5) for DNA:HT (MgAl.26), DNA:LDH 
(ZnAl.11, ZnFe.24 and MgFe.55) complexes were added as shown in Table 3.7. The 
plate was then incubated at 37oC for 84 hours. After 24, 27, 48, 72 and 84 hours 
incubation, each well was observed for GFP fluorescence using an Olympus fluorescence 
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Table 3.7 Culture plate indicating DNA: LDH complexes of each sample added into each 
well. 
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3.4.2.2 Results and discussion 
 
The assay for GFP was utilized in order to determine the optimum incubation period to 
obtain maximum GFP expression, in addition to obtaining a visual account of 
transfection. Thus one sample (containing the highest amount of divalent cation) was 
chosen from each composition group. i.e., MgAl.26, ZnAl.11, ZnFe.24 and MgFe.55. 
Based upon the similar chemistry that the HTs and LDHs exhibit, it was thus concluded 
that other samples not utilized in GFP analysis would yield similar results. 
The expression of GFP as seen by fluorescence measurements, confirms that the HeLa 
cells were successfully transfected. Upon addition of the DNA:HT/LDH material into the 
wells resulted in the complexes gravitating to the bottom of the well shrouding the cells 
(BF images). The sedimentation of theses complexes is ideal in transfecting adherent cell 
lines. Non-adherent cell lines have been used in transfection studies using Mg-Al HTs in 
which the results thus far have proven to be unsuccessful [118]. 
The first sign of GFP expression was noted after 27 hours for DNA: MgAl.26 (Figure 
3.39), with DNA:Zn-Al/Zn-Fe and Mg-Fe LDH complexes showing no fluorescence. 
After 48 hours incubation GFP fluorescence was observed in all wells (Figure 3.40). 
Intensity of fluorescence was found to be the same for all samples. Zn-Fe and Mg-Fe 
LDH samples that showed increased cell proliferation in the cytotoxicity assays 
correlated with the visual appearance of GFP fluorescence due to the high number of 
transfected cells (Figures 3.40 (f), (h), 3.47 (f), (h)). From comparisons of BF images 
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Figure 3.39 GFP fluorescence images (x200) of (a) Cells only (Control) Bight field (BF), 
(b) Control cells UV (c) DNA : MgAl.26 (1: 40) BF , (d) DNA : MgAl.26 (1: 40) UV, 




The intensity of GFP fluorescence appeared to remain constant from 48 hours up until 72 
hours (Figure 3.41) but faded at 96 hours. In addition, cell detachment was observed. As 
the culture medium was not changed over the entire incubation period, the observed cell 
detachment can thus be explained. The decrease in fluorescence could be due to the lack 
of fresh medium and hence an increase in cell apoptosis. In addition, the DNA:HT/LDH 
complexes were observed to shroud the cells, as seen in BF images of GFP expression as 
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Figure 3.40 GFP fluorescence images (x200) of (a) DNA: MgAl.26 (1:40) (BF), (b) DNA: 
MgAl.26 UV (c) DNA: ZnAl.11 (1: 65) BF, (d) DNA: ZnAl.11 (1: 65) UV (e) DNA: 
ZnFe.24 (1: 35) BF, (f) DNA: ZnFe.24 (1: 35) UV (g) DNA: MgFe.55 (1: 30) BF, (h) DNA: 
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Figure 3.41 GFP fluorescence images (x200) of (a) DNA: MgAl.26 (1:40) (BF), (b) 
DNA: MgAl.26 UV (c) DNA: ZnAl.11 (1: 65) BF, (d) DNA: ZnAl.11 (1: 65) UV (e) 
DNA: ZnFe.24 (1: 35) BF, (f) DNA: ZnFe.24 (1: 35) UV (g) DNA: MgFe.55 (1: 30) BF, 
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Figure 3.42 Detached HeLa cell showing HT (MgAl.26) surrounding cell (x200). 
 
The GFP expression over the 96 hour incubation period was shown to be gradual over the 
first 24 hours (prominent in Mg-Al HT sample). HTs have shown a prolonged controlled 
release of pharmaceutics and biomolecules in vitro [25-28, 67, 73, 122]. From nuclease 
digestion observations and DNA release behavior in this study, all HTs and LDHs have 
shown a prolonged release of DNA. This is further supported by the visual analysis of 
GFP expression over the 96 hour incubation period, thus confirming that all the samples 
in this study exhibit a prolonged controlled release of pCMV-DNA in vitro. The 
prolonged release of DNA can be attributed to the buffering capability that HT and LDH 
exhibit once membrane bound within lysosomes.  
Nuclease digestion studies revealed that MgAl.26, MgAl.31, MgAl.34 and ZnFe.32 were 
able to adequately release pCMV-GFP however the released DNA did not match the 
migration of the marker DNA. It was suggested that perhaps the pCMV-GFP was 
modified by HT/LDH binding. However if the DNA was modified to such an extent that 
the GFP gene was damaged in some way, the transcription and translation of the GFP 
gene would thus have been affected which would result in an absence or limited amount 
of GFP. This certainly would have been observed in the GFP assay. Thus as GFP 
expression was not inhibited due to damage or a conformational change in the pCMV-
GFP during release, this suggests that the release mechanism involving SDS is different 
to that of the prolonged acid and enzymatic digestion which occurs within the lysosome. 
Nuclease digestion studies also indicate degradation of DNA; however this degradation 
does not appear to be significant in relation to transfection activity. 
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Since the optimum GFP expression occurred within 48 hours to 72 hours, the latter was 
utilized as the maximum incubation period for quantitative analysis of gene expression 
using the luciferase reporter gene assay. 
 
 
3.4.3 Luciferase transfection assay 
 
3.4.3.1 Materials and methods 
 
All cells were first trypsinized (as per section 3.3.2.4) and seeded into a 48 well plate at a 
cell density of 3.5-4 x 105 cells / well and incubated at 37oC overnight. Reaction 
complexes were prepared as in tables 3.1-3.4, with 1 μg / μl pCMV-luc DNA (The 
Plasmid Factory, Germany). After overnight incubation, the growth medium was 
removed and replaced with 0.5 ml of complete medium into each well. Thereafter the 
reaction complexes for each sample were added to the culture plate as shown in Table 3.8 
overleaf. A similar culture plate layout was employed for each HT/LDH compound 
according to respective optimum binding ratios, including the ratio above and below 
(Tables 3.1-3.4). The same layout was employed throughout all cell lines. The details of 
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Table 3.8 Culture plate indicating DNA: Mg-Al HT complexes of each sample added 
into each well. 




1 : 35 
DNA : 
MgAl.26 
1 : 45 
DNA : 
MgAl.26 
1 : 55 
DNA : 
MgAl.31 
1 : 35 
DNA : 
MgAl.34 
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MgAl.31 








The cells were then incubated at 37 oC for 72 hours. After 72 hours the growth medium 
was removed and cells were washed with PBS. Approximately 60 μl of 1x cell culture 
lysis reagent (Promega Corporation, Madison, USA) was added into each well. The plate 
was then placed on a Stuart Scientific STR 6 platform shaker for 15 minutes at 30 rev / 
minute. The cells were removed by gentle scrapping of the well with a pasteur pipette and 
each cell lysate was from each well was transferred to respective microcentrifuge tubes. 
The samples were centrifuged briefly (5 seconds) at 12 000 x g to pellet out the cell 
debris. Approximately 20 μl of each cell free extract was mixed with 100 μl luciferase 
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assay reagent (Promega Cooperation, Madison, USA) and placed in a Lumac Biocounter 
1500 luminometer and luminescence recorded.  
The residual cell free extract was used in the BCA Assay. A set of standard bovine serum 
albumin (BSA) solutions were prepared in order to construct a standard BSA curve. BSA 
concentrations of 5, 10, 15, 20, 25, 30 ug / 100 μl were prepared from a 1 mg BSA / ml in 
0.15 M NaCl containing 0.05 % sodium azide stock solution (Sigma-Aldrich, Steinheim, 
Germany). In addition a BCA working reagent was prepared, which consisted of 50 parts 
of Bicinchoninic Acid to 1 part of copper (II) sulphate. Thereafter 50 μl of each BSA 
standard solution was mixed with 1 ml of BCA working reagent. Each BSA standard 
solution was then mixed and incubated at 37 oC for 30 minutes. Following incubation, the 
absorbance of each BSA standard solution was determined at a wavelength of 562 nm 
using a Biomate 3 scientific spectrophotometer. The cell free extract was analyzed in a 
similar way. Approximately 50 μl of each cell free extract was added to 1 ml of BCA 
working reagent, this solution was mixed and subsequently incubated at 37 oC for 30 
minutes. This was then followed by the absorbance readings of each cell free extract at 








         124 
 
3.4.3.2 Results and discussion 
 
The incubation time for the luciferase assays was based upon GFP assay observations. 
However shorter incubation times (24 hours and 48 hours) were attempted (data not 
shown) for the luciferase assays all of which showed very low luciferase activities. This 
supports the evidence from the GFP assay as well as the notion that these HT and LDH 
compounds exhibit controlled prolonged release of pCMV-luc intracellularly.  
Highest luciferase activity was observed in the HEK293 cell line with a maximum RLU / 
mg protein value of 16.4 x 106 produced from DNA: MgFe.55 (1:30) (Figure 3.46). The 
luciferase activities in the HepG2 and HeLa cell lines showed similar maxima RLU / mg 
protein values of 0.15-0.4 x 106. 
All DNA: HT / LDH complexes produced higher luciferase activities than the controls in 
the HEK293 cell line. There appeared to be no significant trend in relation to different 
ratios within a HT / LDH composition group or between different composition groups. 
For some samples there were significant standard deviations. These were due to drastic 
jumps in the RLU obtained between each triplicate in a ratio. The MTS assay indicated 
cell proliferation for some samples (Fe containing) in addition the GFP assay showed 
increased transfection for Fe containing samples. However this observed cell 
proliferation did not translate into higher luciferase activities nor did it exhibit similar 
trends seen in the cytotoxicity assays.  
 





Figure 3.43 Luciferase Assay using Mg-Al HT in HEK293 cells. DNA : Mg-Al HT ratios were 
varied (1:30-1:60). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HEK293 cells and a second control sample containing cells and pCMV-luc DNA 
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Figure 3.44 Luciferase Assay using Zn-Al LDH in HEK293 cells. DNA : Zn-Al LDH ratios were 
varied (1:40-1:70). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HEK293 cells and a second control sample containing cells and pCMV-luc DNA 
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Figure 3.45 Luciferase Assay using Zn-Fe LDH in HEK293 cells. DNA : Zn-Fe LDH ratios were 
varied (1:30-1:40). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HEK293 cells and a second control sample containing cells and pCMV-luc DNA 
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Figure 3.46 Luciferase Assay using Mg-Fe LDH in HEK293 cells. DNA : Mg-Fe LDH ratios were 
varied (1:25-1:55). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HEK293 cells and a second control sample containing cells and pCMV-luc DNA 
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Luciferase activities for DNA:HT/LDH complexes in HepG2 cells were much lower than 
that of HEK293 cells. Interestingly, majority of DNA: Zn-Al and Zn-Fe LDHs (Figures 
3.48, 3.49) showed luciferase activities lower than control cells, thus indicating that very 
little pCMV-luc DNA entered into the cells or the DNA itself was degraded and hence 
very little activity seen. From binding assay results, majority of Zn-Al and Zn-Fe samples 
were unable to completely bind all available DNA with more DNA remaining in solution. 
Thus this could explain the lower luciferase activities. Although majority of DNA: Zn-Al 
samples showed lower luciferase activities than the controls, with the maximum 
luciferase activity in HepG2 cells produced by DNA: ZnAl.14 (1:40) (Figure 3.48). The 
lowest luciferase activities in HepG2 cells were produced by DNA: Zn-Fe samples 
(Figure 3.49). 
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Figure 3.47 Luciferase Assay using Mg-Al HT in HepG2 cells. DNA : Mg-Al HT ratios were varied 
(1:30-1:60). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HepG2 cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.48 Luciferase Assay using Zn-Al LDH in HepG2 cells. DNA : Zn-Al LDH ratios were 
varied (1:40-1:70). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HepG2 cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.49 Luciferase Assay using Zn-Fe LDH in HepG2 cells. DNA : Zn-Fe LDH ratios were 
varied (1:30-1:40). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HepG2 cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.50 Luciferase Assay using Mg-Fe LDH in HepG2 cells. DNA : Mg-Fe LDH ratios were 
varied (1:25-1:55). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HepG2 cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Luciferase activities in HeLa cells showed varied results, with some DNA: Zn-Al, Zn-Fe 
and Mg-Fe LDH complexes showing lower activities than control cells. However, 
efficient transfection of HeLa cells with all HT and LDH samples used was observed by 
the GFP assay. The highest luciferase activities in the HeLa cell line were produced from 
DNA: Mg-Al HT complexes (Highest for MgAl.31, 1:60, Figure 3.51). The HeLa cells 
also showed no specific trend for the DNA:HT and LDH complexes. Slight changes in 
the value of x (MIII/MII+MIII) seem to lead to dramatic changes in luciferase values and 
hence the observed dramatic increases and decreases in RLU between samples. 
The luciferase activities in the three cell lines produced using DNA:HT/LDH samples, on 
average was fairly active. In the HepG2 and HeLa cell lines, majority of DNA: Zn-Al and 
Zn-Fe complexes exhibit poor luciferase activity. When comparing all cell lines, 
DNA:Mg-Al HTs appear to be the most efficient, followed by DNA:Mg-Fe LDHs and 
lastly DNA:Zn-Al/Zn-Fe samples. In terms of specific cell lines, DNA:Mg-Fe LDHs 
exhibit the highest luciferase activity in the HEK293 cell line. DNA:Zn-Fe LDHs exhibit 
the highest luciferase activity in the HepG2 cell line and DNA:Mg-Al LDHs in the HeLa 
cell line. Thus, from the results of the luciferase transfection assay it can be seen that HTs 
and LDHs have the ability to efficiently deliver DNA into mammalian cells in culture. 
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Figure 3.51 Luciferase Assay using Mg-Al HT in HeLa cells. DNA : Mg-Al HT ratios were varied 
(1:30-1:60). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HeLa cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.52 Luciferase Assay using Zn-Al LDH in HeLa cells. DNA : Zn-Al LDH ratios were 
varied (1:40-1:70). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HeLa cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.53 Luciferase Assay using Zn-Fe LDH in HeLa cells. DNA : Zn-Fe LDH ratios were 
varied (1:30-1:40). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HeLa cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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Figure 3.54 Luciferase Assay using Mg-Fe LDH in HeLa cells. DNA : Mg-Fe LDH ratios were 
varied (1:25-1:55). pCMV-luc DNA used was kept constant at 1.0 μg. Two controls were used, one 
containing only HeLa cells and a second control sample containing cells and pCMV-luc DNA (1.0 
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All HT (Mg-Al) and LDH (Zn-Al, Zn-Fe and Mg-Fe) compounds were successfully 
synthesized using co-precipitation. Hydrotalcites and LDHs containing these cations have 
been previously mentioned in literature, however to our knowledge the values of x for 
Zn-Al and Mg-Fe LDHs reported in the current study have not been evaluated prior to 
this. Significantly, values of x as low as 0.11-0.16 for Zn-Al LDHs were recorded. 
Elemental analysis confirmed higher amounts of zinc in these compounds. It was 
concluded that the higher amounts of zinc was attributed to electrostatic repulsion 
between trivalent metals. This is a result of substitutions of Zn2+ by Al3+ within the 
brucite-like layer, however the accumulation of Al3+ ions increases electrostatic repulsion 
between neighbouring Al3+ ions. The repulsion of trivalent Al, results in more positions 
within the brucite-layer being left vacant for Zn2+ to fill. Rojas Delgado et al. [135] 
observed similar findings in their studies of Zn-Al LDHs. Mg-Fe LDHs exhibited higher 
values of x ranging from 0.55-0.62. Elemental analysis revealed a fairly even distribution 
of Mg and Fe which could be attributed to the fact that these cations have very similar 
ionic radii. All Mg-Al HT, Zn-Al and Mg-Fe LDH XRD data and diffractograms were 
consistent with literature findings with the exception of Zn-Fe LDHs. The XRD data for 
Zn-Fe LDHs indicated the presence of ZnFe204 and Fe2O3 species confirmed form JCPDS 
data. (22-1012 ZnFe204 and 24-72 (Fe2O3)10R Hematite). X-ray diffractograms for Mg-
Al HTs and Zn-Al and Mg-Fe LDHs exhibited intense symmetric lines at low 2θ values 
and less intense asymmetric lines at higher 2θ values, including the distinctive doublet 
peak at a 2θ value of 60o indicative of a layered material which is distinctive of a 
hydrotalcite-like structure. The vibrational structure and characteristic functional moieties 
of the compounds were confirmed through FTIR and Raman spectroscopy. Electron 
microscopy revealed particles exhibiting classical morphologies typical of HT and LDH 
compounds and had an average lateral size of 200-300 nm. Significantly, sonication of 
inorganic compounds in ethanol for 30 minutes prior to viewing ensures adequate particle 
distribution and prevents compound aggregation.  
 140 
Currently, Mg-Al HTs have been reported in literature having applications in gene 
delivery. To our knowledge Zn-Al, Zn-Fe and Mg-Fe LDHs being utilized in gene 
delivery is novel to the field of inorganic compound based gene delivery.  
All of the HT and LDH compounds were studied in their ability to bind DNA and 
effectively deliver DNA to mammalian cells in culture was explored. All of the HT and 
LDH compounds exhibited the ability to bind DNA to varying degrees through a gel 
retardation assay or band shift assay. The mechanism of DNA binding to HT was 
examined through XRD, FTIR, Raman spectroscopy and electron microscopy. Two 
plausible mechanisms were proposed. The first being partial ion exchange of DNA for 
the HT anion interlayer, with the remainder of DNA protruding into the reaction solution. 
The protruding DNA is then able to partially intercalate, via ion exchange into the 
interlayer of a second HT particle forming aggregates of DNA: HT complexes. The 
alternative mechanism to the former, is one in which DNA bound to the peripheral 
surface of a HT particle with no ion exchange occurring. Therefore once DNA had bound 
to the exterior of one particle, a second or third HT particle would thus bind to the 
exposed DNA and thus sandwich the DNA within an aggregation of two or more HT 
particles. Previous studies using HTs (Mg-Al) in gene delivery have indicated complete 
ion exchange mechanism. 
Nuclease digestion assays were carried out in order to evaluate the ability of these 
compounds protect the bound DNA in the presence of serum. It was observed that all 
compounds had the ability to protect most of the bound DNA. The cytotoxicity of the 
compounds was evaluated in the HEK293, HepG2 and HeLa mammalian cell lines using 
the MTS assay. Most of the compounds exhibited cell viabilities in excess of 80 %. 
Significantly, there appears to be no published data on the toxicity of Zn-Al, Zn-Fe or 
Mg-Fe LDHs in literature. Finally, transfection studies were carried out utilizing green 
fluorescent protein (GFP) analysis and luciferase gene expression in the above 
mammalian cells in culture. It was noted that all HTs and LDHs were able to release 
DNA in a controlled prolonged manner over a period of three days. Gene expression 
(GFP) commenced after 27 hours and reached a maximum at 72 hours. Efficient gene 
expression was observed with luciferase activities for DNA: HTs ranging from 0.05 x 106 
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- 2.0 x 106 RLU / mg protein and DNA: LDHs ranging from 0.05 x 106 - 16.7 x 106 RLU/ 
mg protein. Highest luciferase activity was recorded as 16.7 x 106 RLU / mg protein. 
 
From this study, it can be demonstrated that HTs and LDHs compounds have immense 
promise in gene delivery strategies. A number of significant findings relating to the 
chemistry and biochemistry of HT and LDHs compounds in this study have not been 
described in literature prior to this. These findings are indeed a positive and invaluable 
contribution to the understanding and capacity development of HTs and LDHs for their 
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Synthesis of HTs and LDHs 
 
Calculations of required amounts of precursors for the synthesis of HTs and LDHs: 
 
A typical calculation for the preparation of Mg6Al2(OH)16 (CO3)2-.4H20 HT. 
For x = 0.25, i.e. Mg: Al = 3: 1 
 
Mg(NO3)2.6H20 (0.15 M) 
Mass of Mg(NO3)2.6H20 required = 0.15 mol x 256 g. mol-1 
           = 38.4 g 
 
Al(NO3)2.9H20 (0.05 M) 
Mass of Al(NO3)2.6H20 required  = 0.05 mol x 375 g. mol-1 
           = 18.75 g 
 
NaOH (1.0 M) 
Mass of NaOH required        = 1.0 mol. dm-3  x 0.4 dm-3  x 40 g. mol-1  
       = 16 g 
for 400 ml of solution. 
 
Na2CO3 (1.0 M) 
Mass of Na2CO3 required         = 1.0 mol. dm-3  x 0.25 dm-3  x 106 g. mol-1  







Table A1 Details for the synthesis of HT and LDH materials 
 Mass (g) 
Compound x MII MIII NaOH Na2CO3 
MgAl.25 0.26 38.4 18.75 16 26.5 
MgAl.31 0.31 29.44 18.75 16 26.5 
MgAl.34 0.34 51.2 37.5 16 26.5 
ZnAl.11 0.11 44.5 18.75 16 26.5 
ZnAl.14 0.14 34.155 18.75 16 26.5 
ZnAl.16 0.16 59.4 37.5 16 26.5 
ZnFe.24 0.24 44.5 14.35 16 26.5 
ZnFe.30 0.30 34.155 14.35 16 26.5 
ZnFe.32 0.32 59.4 28.7 16 26.5 
MgFe.55 0.55 38.4 14.35 16 26.5 
MgFe.58 0.58 29.44 14.35 16 26.5 

















HT and LDH Physical Properties 
 
Table A2 Physical appearance and properties of HT and LDH products. 
Sample 
Physical properties 




Not soluble, remains as a 




Not soluble, remains as a 




Not soluble, remains as a 
sediment / pellet. 
ZnAl.11 White 
Fine powder, 
Pliable, greasy feel. 
Not soluble, remains as a 
sediment / pellet. 
ZnAl.14 White 
Fine powder, 
Pliable, greasy feel. 
Not soluble, remains as a 
sediment / pellet. 
ZnAl.16 White 
Fine powder, 
Pliable, greasy feel. 
Not soluble, remains as a 




Not soluble, remains as a 




Not soluble, remains as a 




Not soluble, remains as a 
sediment / pellet. 
MgFe.55 White 
Fine powder, 
Pliable feel, satiny/slight 
shimmer. 
Slightly soluble, remains in 






Pliable feel, satiny/slight 
shimmer. 
Slightly soluble, remains in 




Not soluble, remains as a 





Figure A1 Solubility of HTs and LDHs in 18 mohm water, HT / LDH concentration = 10 
μg / μl. Total volume in tube, approximately 0.8 ml. (a) MgAl.26 (b) MgAl.31 (c) 
MgAl.34 (d) ZnAl.11 (e) ZnAl.14 (f) ZnAl.16 (g) ZnFe.24 (h) ZnFe.30 (i) ZnFe.32 (j) 







Figure A2 Solubility of HTs and LDHs in 18 mohm water, 30 minutes after 20 minutes 
sonication. HT / LDH concentration = 10 μg / μl. Total volume in tube, approximately 
0.8 ml. (a) MgAl.26 (b) MgAl.31 (c) MgAl.34 (d) ZnAl.11 (e) ZnAl.14 (f) ZnAl.16 (g) 







Synthesis and Characterization of HTs and LDHs 
Table A3 d-basal spacing values for Mg-Al HTs, Zn-Al, Zn-Fe and Mg-Fe LDHs. 
 Basal spacing / Å 
Compound MII : MIII d003  d006  d012  d015  d018  d110  d113  
MgAl.25 0.25 7.90 3.92 2.60 2.32 1.97 1.53 1.50 
MgAl.31 0.30 7.77 3.85 2.59 2.31 1.96 1.53 1.50 
MgAl.34 0.33 7.69 3.82 2.57 2.29 1.94 1.52 1.49 
ZnAl.11 0.11 7.69 3.81 2.60 2.30 1.94 1.54 1.50 
ZnAl.14 0.14 7.71 3.82 2.60 2.30 1.95 1.54 1.50 
ZnAl.16 0.16 7.69 3.81 2.60 2.30 1.94 1.53 1.50 
ZnFe.24 0.25 6.87 3.70 2.58 2.32 1.96 1.58 1.59 
ZnFe.30 0.30 6.87 3.70 2.58 2.32 1.96 1.58 1.59 
ZnFe.32 0.33 6.89 3.70 2.58 2.32 1.96 1.58 1.59 
MgFe.55 0.55 7.85 3.90 2.63 2.33 1.99 1.55 1.52 
MgFe.58 0.58 7.84 3.89 2.63 2.35 1.99 1.55 1.52 
MgFe.62 0.62 7.83 3.89 2.63 2.35 2.01 1.55 1.52 
 
Table A4 FWHM and respective 2θ-values for Mg-Al HTs, Zn-Al, Zn-Fe and Mg-Fe LDHs. 
Compound MII:MIII 2θ-value FWHM* 
MgAl.25 0.25 11.179 0.84 
MgAl.31 0.30 11.374 0.833 
MgAl.34 0.33 11.495 0.549 
ZnAl.11 0.11 11.496 0.256 
ZnAl.14 0.14 11.459 0.267 
ZnAl.16 0.16 11.494 0.261 
ZnFe.24 0.25 12.833 0.814 
ZnFe.30 0.30 12.833 0.83 
ZnFe.32 0.33 12.828 0.829 
MgFe.55 0.55 11.251 0.627 
MgFe.58 0.58 11.274 0.771 
MgFe.62 0.62 11.278 0.675 
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Figure A11 TEM images of (a) MgAl.26 (x75k), (b) MgAl.31 (x200k),  









Figure A12 TEM images of (a) ZnAl.11 (x40k), (b) ZnAl.14 (x200k), and 
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Figure A13 TEM images of (a) ZnFe.24 (x75k), (b) ZnFe.30 (x100k),  
and (c) ZnFe.32 (x100k). 
     
 
Figure A14 TEM images of (a) MgFe.55 (x100k), (b) MgFe.58 (x150k),  
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 Mg   Al   O  
Figure A15 SEM-EDX spectrum for MgAl.26. 
 
 
Table A5 SEM-EDX elemental data for MgAl.26. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  18.85   42.24   53.41             0.00          0.00    1.4 
Mg 12 K-series  17.65   39.55   32.93      MgO   65.59         29.27    1.0 
Al 13 K-series   8.13   18.21   13.66    Al2O3   34.41         15.36    0.4 
--------------------------------------------------------------------------- 
































Figure A16 SEM-EDX spectrum for MgAl.31. 
 
 
Table A6 SEM-EDX elemental data for MgAl.31. 
 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  21.62   42.57   53.87             0.00          0.00    1.6 
Mg 12 K-series  18.68   36.79   30.65      MgO   61.01         30.98    1.1 
Al 13 K-series  10.48   20.64   15.48    Al2O3   38.99         19.80    0.5 
--------------------------------------------------------------------------- 

































Figure A17 SEM-EDX spectrum for MgAl.34. 
 
 
Table A7 SEM-EDX elemental data for MgAl.34. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  17.29   42.87   54.28             0.00          0.00    1.3 
Mg 12 K-series  13.85   34.34   28.62      MgO   56.95         22.97    0.8 
Al 13 K-series   9.19   22.78   17.10    Al2O3   43.05         17.37    0.5 
--------------------------------------------------------------------------- 


















































Figure A18 SEM-EDX spectrum for ZnAl.11. 
 
 
Table A8 SEM-EDX elemental data for ZnAl.11. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
              [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  17.33   24.69   53.09             0.00          0.00    1.0 
Al 13 K-series   6.81    9.71   12.38    Al2O3   18.34         12.87    0.4 
Zn 30 K-series  46.05   65.61   34.53      ZnO   81.66         57.32    1.3 
--------------------------------------------------------------------------- 













































Figure A19 SEM-EDX spectrum for ZnAl.14. 
 
 
Table A9 SEM-EDX elemental data for ZnAl.14. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  21.98   25.84   53.67             0.00          0.00    1.3 
Al 13 K-series  10.15   11.93   14.69    Al2O3   22.54         19.17    0.5 
Zn 30 K-series  52.94   62.24   31.63      ZnO   77.46         65.90    1.5 
--------------------------------------------------------------------------- 













































Figure A20 SEM-EDX spectrum for ZnAl.16. 
 
 
Table A10 SEM-EDX elemental data for ZnAl.16. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  19.44   26.33   53.91             0.00          0.00    1.1 
Al 13 K-series   9.51   12.87   15.63    Al2O3   24.33         17.96    0.5 
Zn 30 K-series  44.90   60.80   30.46      ZnO   75.67         55.88    1.3 
--------------------------------------------------------------------------- 
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Figure A21 SEM-EDX spectrum for ZnFe.24. 
 
 
Table A11 SEM-EDX elemental data for ZnFe.24. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  14.75   21.78   52.47             0.00          0.00    0.6 
Fe 26 K-series   9.68   14.30    9.87    Fe2O3   20.45         13.85    0.3 
Zn 30 K-series  43.29   63.92   37.67      ZnO   79.55         53.88    1.2 
--------------------------------------------------------------------------- 
















































Figure A22 SEM-EDX spectrum for ZnFe.30. 
 
 
Table A12 SEM-EDX elemental data for ZnFe.30. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  14.01   22.06   52.77             0.00          0.00    0.6 
Fe 26 K-series  10.26   16.15   11.07    Fe2O3   23.10         14.66    0.3 
Zn 30 K-series  39.23   61.79   36.16      ZnO   76.90         48.83    1.1 
--------------------------------------------------------------------------- 
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Figure A23 SEM-EDX spectrum for ZnFe.32. 
 
 
Table A13 SEM-EDX elemental data for ZnFe.32. 
El AN  Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
               [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
--------------------------------------------------------------------------- 
O  8  K-series  17.41   22.31   53.03             0.00          0.00    0.7 
Fe 26 K-series  13.90   17.81   12.13    Fe2O3   25.46         19.87    0.4 
Zn 30 K-series  46.73   59.88   34.84      ZnO   74.54         58.16    1.3 
--------------------------------------------------------------------------- 












































Figure A24 SEM-EDX spectrum for MgFe.55. 
 
 
Table A14 SEM-EDX elemental data for MgFe.55. 
Element    Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
                   [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
------------------------------------------------------------------------------- 
Magnesium K-series  24.42   39.66   37.64      MgO   65.76         40.50    1.4 
Iron      K-series  14.75   23.95    9.89    Fe2O3   34.24         21.09    0.4 
Oxygen    K-series  22.42   36.40   52.47             0.00          0.00    1.4 
------------------------------------------------------------------------------- 













































Figure A25 SEM-EDX spectrum for MgFe.58. 
 
 
Table A15 SEM-EDX elemental data for MgFe.58. 
Element    Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
                   [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
------------------------------------------------------------------------------- 
Magnesium K-series  18.58   35.08   34.39      MgO   58.17         30.81    1.0 
Iron      K-series  15.50   29.26   12.48    Fe2O3   41.83         22.16    0.4 
Oxygen    K-series  18.89   35.66   53.12             0.00          0.00    1.2 
------------------------------------------------------------------------------- 








































Figure A26 SEM-EDX spectrum for MgFe.62. 
 
 
Table A16 SEM-EDX elemental data for MgFe.62. 
Element    Series  unn. C norm. C Atom. C Compound Comp. C norm. Comp. C  Error 
                   [wt.%]  [wt.%]  [at.%]           [wt.%]        [wt.%] [wt.%] 
------------------------------------------------------------------------------- 
Magnesium K-series  20.76   33.10   32.93      MgO   54.89         34.43    1.2 
Iron      K-series  19.79   31.55   13.66    Fe2O3   45.11         28.29    0.6 
Oxygen    K-series  22.17   35.35   53.41             0.00          0.00    1.4 
------------------------------------------------------------------------------- 










Table A17 Culture plate arrangement indicating concentration (μg/10 μl) of each Zn-Al 
LDH sample added into each well. 













































































































Table A18 Culture plate arrangement indicating concentration (μg/10 μl) of each Zn-Fe 
LDH sample added into each well. 


















































































































Table A19 Culture plate arrangement indicating concentration (μg/10 μl) of each Mg-Fe 
LDH sample added into each well. 




















































































































Table A20 Culture plate indicating DNA: Zn-Al LDH complexes of each sample added 
into each well. 































































































































Table A21 Culture plate indicating DNA: Zn-Fe LDH complexes of each sample added 
into each well. 































































































































Table A22 Culture plate indicating DNA: Mg-Fe LDH complexes of each sample added 
into each well. 
Well 2 3 4 5 6 7 
A1 
(Control) 
Cells 
1:25 
DNA : 
MgFe.55 
1:35 
DNA : 
MgFe.55 
1:50 
DNA : 
MgFe.58 
1:30 
DNA : 
MgFe.62 
1:40 
DNA : 
MgFe.62 
Empty 
well 
B 
(Control) 
Cells 
1:25 
DNA : 
MgFe.55 
1:35 
DNA : 
MgFe.55 
1:50 
DNA : 
MgFe.58 
1:30 
DNA : 
MgFe.62 
1:40 
DNA : 
MgFe.62 
Empty 
well 
C 
(Control) 
Cells 
1:25 
DNA : 
MgFe.55 
1:35 
DNA : 
MgFe.55 
1:50 
DNA : 
MgFe.58 
1:30 
DNA : 
MgFe.62 
1:40 
DNA : 
MgFe.62 
Empty 
well 
D 
1 μg 
pCMV-luc 
1:30 
DNA : 
MgFe.55 
1:45 
DNA : 
MgFe.58 
1:55 
DNA : 
MgFe.58 
1:35 
DNA : 
MgFe.62 
Empty 
well 
Empty 
well 
E 
1 μg 
pCMV-luc 
1:30 
DNA : 
MgFe.55 
1:45 
DNA : 
MgFe.58 
1:55 
DNA : 
MgFe.58 
1:35 
DNA : 
MgFe.62 
Empty 
well 
Empty 
well 
F 
1 μg 
pCMV-luc 
1:30 
DNA : 
MgFe.55 
1:45 
DNA : 
MgFe.58 
1:55 
DNA : 
MgFe.58 
1:35 
DNA : 
MgFe.62 
Empty 
well 
Empty 
well 
 
 
 
